George D Dangas

Q: What Schools Are Affiliated With George D Dangas

George D Dangas is affiliated with the following schools: Yale University, American College of Cardiology, Showa University, Icahn School of Medicine at Mount Sinai, National and Kapodistrian University of Athens, Columbia University, Paris Diderot University, Duke University

George D Dangas's AcademicInfluence.com Rankings

George D Dangas

Engineering

#2614

World Rank

#3570

Historical Rank

Biomedical Engineering

#76

World Rank

#77

Historical Rank

engineering Degrees

George D Dangas

Philosophy

#3916

World Rank

#6249

Historical Rank

Logic

#1500

World Rank

#2267

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

George D Dangas's Degrees

PhD Biomedical Engineering Columbia University

Why Is George D Dangas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

George D Dangas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. (2004) (2200)
Bivalirudin during primary PCI in acute myocardial infarction. (2008) (1816)
Strategies for multivessel revascularization in patients with diabetes. (2012) (1569)
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. (1999) (1242)
Incidence (1931) (868)
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. (2007) (849)
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. (2005) (741)
In-stent restenosis in the drug-eluting stent era. (2010) (668)
A risk score to predict bleeding in patients with acute coronary syndromes. (2010) (640)
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. (2005) (558)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) (539)
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial (2017) (503)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial (2018) (486)
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. (2004) (477)
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial (2011) (458)
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. (2009) (455)
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. (2005) (440)
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. (2002) (416)
Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II (2005) (411)
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial (2009) (408)
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. (2011) (402)
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. (2002) (383)
Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. (2004) (365)
Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention: Results of the GOLD (AU-Assessing Ultegra) Multicenter Study (2001) (360)
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (2011) (356)
Comparative effectiveness of revascularization strategies. (2012) (345)
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. (2009) (344)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 (2020) (335)
Stroke After Coronary Artery Bypass: Incidence, Predictors, and Clinical Outcome (2001) (326)
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. (2015) (306)
Long-term outcome of percutaneous coronary intervention for chronic total occlusions. (2011) (286)
Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis (2004) (282)
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. (2011) (278)
Prosthetic Heart Valve Thrombosis. (2016) (278)
Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients. (2000) (275)
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. (2019) (272)
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. (2007) (260)
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. (2011) (260)
Characterization of Myocardial Injury in Patients With COVID-19 (2020) (260)
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. (2011) (254)
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. (2004) (246)
Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques: A Comparison of Culprit and Nonculprit Lesions of Patients With Acute Coronary Syndromes and Lesions in Patients Without Acute Coronary Syndromes (2003) (242)
Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. (1999) (240)
Acute renal failure requiring dialysis after percutaneous coronary interventions (2001) (235)
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. (2001) (233)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial (2020) (217)
Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients (2001) (211)
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. (2005) (211)
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. (2014) (209)
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. (2012) (207)
Predictors of Long-Term Survival After Coronary Artery Bypass Grafting Surgery: Results From the Society of Thoracic Surgeons Adult Cardiac Surgery Database (The ASCERT Study) (2012) (202)
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). (2013) (199)
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. (1999) (198)
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. (2008) (196)
Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2011) (190)
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. (2004) (189)
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. (2005) (186)
A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. (1998) (186)
Intravascular Ultrasound Findings of Early Stent Thrombosis After Primary Percutaneous Intervention in Acute Myocardial Infarction: A Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Substudy (2011) (185)
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. (2002) (182)
Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study. (2013) (181)
Intravascular Ultrasound Classification of Plaque Distribution in Left Main Coronary Artery Bifurcations: Where Is the Plaque Really Located? (2010) (180)
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (176)
Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention (2001) (175)
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. (2000) (173)
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. (2008) (166)
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. (2008) (166)
Postprocedural hypotension after carotid artery stent placement: predictors and short- and long-term clinical outcomes. (2000) (163)
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. (2009) (159)
Contrast-Associated Acute Kidney Injury. (2019) (157)
Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. (2000) (157)
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention (2018) (156)
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. (2009) (155)
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. (2019) (146)
Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. (2016) (143)
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention (2016) (143)
Stent thrombosis: a clinical perspective. (2014) (142)
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. (2019) (141)
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. (2014) (140)
Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. (1999) (139)
Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure (2002) (138)
Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. (1998) (138)
Short- and long-term results after multivessel stenting in diabetic patients. (2004) (137)
Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (137)
Management of restenosis after coronary intervention. (1996) (134)
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial (2016) (131)
Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study. (2015) (131)
Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results (2005) (129)
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials (2015) (128)
Nonuniform Strut Distribution Correlates With More Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation (2004) (126)
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. (2002) (126)
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (124)
Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. (2015) (122)
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents. (2017) (119)
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. (2009) (119)
Rotational atherectomy for in-stent restenosis: acute and long-term results of the first 100 cases. (1998) (117)
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. (2006) (113)
Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. (2009) (113)
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. (2015) (112)
Atrial fibrillation after beating heart surgery. (2000) (112)
Gender-specific outcomes after sirolimus-eluting stent implantation. (2007) (111)
Coronary artery aneurysms after drug-eluting stent implantation. (2008) (111)
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap. (2020) (110)
Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect (2000) (109)
Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial (2015) (109)
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). (2014) (108)
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials. (2009) (107)
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. (2005) (107)
Correlation of angiographic morphology and clinical presentation in unstable angina. (1997) (106)
Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. (2011) (105)
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. (2020) (104)
Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. (2012) (103)
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. (2016) (103)
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. (2011) (102)
Open versus endovascular stent graft repair of abdominal aortic aneurysms: a meta-analysis of randomized trials. (2012) (102)
Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS‐AMI trial (2014) (100)
Preintervention arterial remodeling as an independent predictor of target-lesion revascularization after nonstent coronary intervention: an analysis of 777 lesions with intravascular ultrasound imaging. (1999) (100)
Beating heart surgery in octogenarians: perioperative outcome and comparison with younger age groups. (2000) (100)
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. (2012) (97)
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials (2021) (96)
Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. (2009) (96)
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study (2017) (96)
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). (2005) (94)
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials. (2019) (94)
A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention (2003) (93)
Cardiovascular morbidity and mortality of the metabolic syndrome. (2007) (91)
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration (2019) (90)
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. (2006) (89)
The impact of multivessel disease with and without a co‐existing chronic total occlusion on short‐ and long‐term mortality in ST‐elevation myocardial infarction patients with and without cardiogenic shock (2013) (89)
Cerebral Embolic Protection During TAVR: A Clinical Event Meta-Analysis. (2017) (87)
Beating heart versus conventional single-vessel reoperative coronary artery bypass. (2000) (87)
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. (2007) (85)
Prediction of Long-Term Mortality After Percutaneous Coronary Intervention in Older Adults: Results From the National Cardiovascular Data Registry (2012) (84)
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. (2006) (83)
A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". (2006) (83)
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. (2001) (83)
Rotational atherectomy: Improved procedural outcome with evolution of technique and equipment. single‐center results of first 1,000 patients (1999) (82)
Assessing intermediate left main coronary lesions using intravascular ultrasound. (2007) (82)
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. (2010) (79)
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). (2010) (79)
Reperfusion Strategies in Acute Coronary Syndromes (2014) (79)
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. (2021) (79)
Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials. (2014) (79)
Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. (2012) (78)
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). (2006) (78)
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. (2009) (77)
Update on In-stent Restenosis. (2001) (77)
Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. (2011) (77)
Restenosis: Repeat Narrowing of a Coronary Artery Prevention and Treatment (2002) (76)
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. (2009) (75)
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions (2018) (74)
Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques. (2005) (74)
Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. (2008) (74)
Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: The peripheral arterial disease in Interventional Patients Study (2009) (74)
Contrast‐induced nephropathy (2008) (73)
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. (1998) (73)
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial. (2019) (72)
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. (2002) (71)
Dual catheter technique for the treatment of severe coronary artery perforations (2010) (71)
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. (2009) (71)
Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. (2003) (70)
Stroke After Transcatheter Aortic Valve Replacement: Incidence, Risk Factors, Prognosis, and Preventive Strategies (2014) (69)
Incidence, Predictors, and Implications of Reinfarction After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial (2014) (69)
Impact of Leukocyte Count on Mortality and Bleeding in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Interventions: Analysis From the Harmonizing Outcome With Revascularization and Stent in Acute Myocardial Infarction Trial (2011) (67)
Viral Coagulopathy in Patients With COVID-19: Treatment and Care (2020) (67)
Ticagrelor With or Without Aspirin After Complex PCI (2020) (66)
Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. (2004) (66)
ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3) (2015) (66)
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. (2008) (65)
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. (2020) (65)
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. (2009) (64)
Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. (2015) (64)
5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial. (2011) (63)
Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer‐generation DES: Findings from a large multiethnic registry (2018) (63)
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. (2011) (62)
Transplantation of Autologous Endothelial Cells Induces Angiogenesis (2003) (61)
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. (2008) (61)
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. (2002) (60)
Female gender and mortality after percutaneous coronary intervention: Results from a large registry (2012) (60)
Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (60)
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients (2017) (58)
Thrombo-embolic prevention after transcatheter aortic valve implantation (2017) (58)
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. (2008) (57)
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease. (2016) (56)
Radiocontrast-Induced Acute Renal Failure—Impact beyond the Acute Phase Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables. Am J Cardiol 95: 13–19, 2005 (2006) (54)
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials. (2018) (54)
Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. (2000) (54)
Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. (2005) (53)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis. (2016) (53)
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement (2019) (53)
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy. (2020) (53)
Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). (2012) (53)
Risk factors for the development of slow flow during rotational coronary atherectomy. (1997) (52)
Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study. (2014) (52)
New Insights Into the Risk Factors of Contrast-Induced Encephalopathy (2011) (52)
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. (2011) (51)
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (51)
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE‐TAVI AF trial (2018) (51)
Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. (2012) (51)
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association (2021) (51)
Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke: From the CENTER-Collaboration (2019) (50)
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. (2012) (50)
Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. (2001) (49)
Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). (2014) (49)
Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study. (2016) (49)
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes (2019) (49)
Impact of target vessel on long‐term survival after percutaneous coronary intervention for chronic total occlusions (2013) (48)
Impact of myocardial bridge on clinical outcome after coronary stent placement. (2009) (48)
Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. (2001) (47)
Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention. (2020) (47)
Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? (2020) (47)
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
The current role and future prospects of D-dimer biomarker. (2016) (46)
Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion. (2012) (46)
COCATS 4 Task Force 10: Training in Cardiac Catheterization. (2015) (45)
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. (2005) (45)
D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy (2013) (44)
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. (2017) (44)
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention. (2019) (44)
Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. (2001) (44)
Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease. (1999) (43)
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. (2008) (43)
Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions. (2012) (43)
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old. (2003) (42)
Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). (2014) (42)
Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions. (2000) (41)
Predictors and Implications of Stent Thrombosis in Non–ST-Segment Elevation Acute Coronary Syndromes: The ACUITY Trial (2011) (41)
Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial. (2012) (41)
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. (2012) (41)
Impact of Symptomatic Peripheral Arterial Disease on 1-Year Mortality in Patients Undergoing Percutaneous Coronary Interventions (2004) (40)
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial. (2009) (40)
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. (2011) (40)
Impact of Initial Evolut Transcatheter Aortic Valve Replacement Deployment Orientation on Final Valve Orientation and Coronary Reaccess. (2019) (40)
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. (2017) (39)
One-Year Clinical Outcome After Minimally Invasive Direct Coronary Artery Bypass (2000) (39)
B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial (2012) (39)
Gender Differences in Transfemoral Transcatheter Aortic Valve Replacement. (2019) (39)
Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis. (2020) (39)
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial). (2004) (39)
Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis. (2014) (38)
Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. (2011) (38)
Unstable angina: current concepts of pathogenesis and treatment. (2000) (38)
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2015) (38)
Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index. (2015) (38)
Spontaneous coronary artery dissection. (1998) (37)
Feasibility of Repeat TAVR After SAPIEN 3 TAVR: A Novel Classification Scheme and Pilot Angiographic Study. (2019) (37)
Transient contrast encephalopathy after carotid artery stenting. (2001) (37)
Incidence and mechanism of creatine kinase‐MB enzyme elevation after coronary intervention with different devices (1999) (37)
Restenosis due to underexpansion of sirolimus‐eluting stent in a bifurcation lesion (2003) (35)
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. (2013) (34)
Contemporary overview and clinical perspectives of chronic total occlusions (2014) (34)
Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. (2010) (34)
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial (2011) (34)
Advanced c‐myc antisense (AVI‐4126)‐eluting phosphorylcholine‐coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model (2004) (34)
Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies (2005) (33)
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (33)
Angiographic patterns of in‐stent restenosis and implications on subsequent revascularization (2000) (33)
Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. (2015) (33)
Successful use of the frontrunner catheter in the treatment of in‐stent coronary chronic total occlusions (2004) (33)
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin. (1999) (32)
Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy). (2013) (32)
Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (32)
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). (2015) (32)
Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). (2017) (32)
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). (2011) (31)
Intravascular ultrasound-guided renal artery stenting. (2001) (31)
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention. (2007) (31)
Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention. (2002) (31)
Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible? (2010) (31)
Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease. (2004) (31)
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents (2011) (31)
Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis. (2011) (31)
Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials (2021) (31)
Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof? (2013) (31)
The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study. (2015) (31)
Effect of Short Pulsed Nonablative Infrared Laser Irradiation on Vascular Cells In Vitro and Neointimal Hyperplasia in a Rabbit Balloon Injury Model (2001) (30)
Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting. (2000) (30)
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial (2019) (30)
Antithrombotic effects of abciximab. (2000) (30)
Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis. (2014) (30)
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings. (2011) (30)
ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies. (2010) (30)
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention (2017) (30)
Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary Syndrome. (2016) (30)
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors. (2002) (29)
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. (2018) (29)
Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials. (2017) (29)
Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions ) (2009) (28)
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (2021) (28)
The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation. (2011) (28)
Study of atheromatous plaque using intravascular ultrasound. (2008) (28)
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. (2003) (28)
The role of mucomyst administration prior to percutaneous interventions on renal function in patients with chronic renal failure (2002) (28)
Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. (2004) (27)
In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site. (1999) (27)
Prevalence of autoantibodies against contractile proteins in coronary artery disease and their clinical implications. (2000) (27)
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (27)
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography. (2018) (27)
Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies (2013) (26)
Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. (1999) (26)
Colchicine in Cardiovascular Disease: In-Depth Review. (2022) (26)
Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. (2004) (25)
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (25)
In vivo demonstration of an antithrombin effect of abciximab. (2000) (25)
Long‐term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥75 Years) (2013) (25)
Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art Review. (2022) (25)
Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy (2003) (25)
Transient Contrast Encephalopathy after Carotid Artery Stenting (2001) (25)
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. (2004) (25)
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. (2021) (25)
Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. (2003) (25)
Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy (2011) (24)
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque. (2005) (24)
Resistant in‐stent restenosis in the drug eluting stent era (2016) (24)
Cardiovascular magnetic resonance imaging evaluation of two families with Becker muscular dystrophy (2010) (24)
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. (2003) (24)
Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty. (2014) (24)
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study. (2017) (23)
Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST‐segment elevation myocardial infarction: Results of the HORIZONS‐AMI trial (2015) (23)
Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. (2013) (23)
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry (2021) (23)
Percutaneous mitral valve repair: lessons from the EVEREST II (Endovascular Valve Edge-to-Edge REpair Study) and beyond. (2011) (23)
Real world safety and efficacy of the Janus tacrolimus‐eluting stent: Long‐term clinical outcome and angiographic findings from the tacrolimus‐eluting stent (TEST) registry (2009) (23)
Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration. (2019) (23)
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
Cardiology patient page. Restenosis: repeat narrowing of a coronary artery: prevention and treatment. (2002) (23)
New-Device Angioplasty in Women: Clinical Outcome and Predictors in a 7,372-Patient Registry (2002) (22)
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries. (2002) (22)
Antithrombotic Treatment after Transcatheter Heart Valves Implant (2018) (22)
Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention. (1999) (22)
Vascular Closure Devices (2005) (22)
Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery. (2002) (22)
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (22)
Balloon optimization versus stent study (BOSS): provisional stenting and early recoil after balloon angioplasty. (2000) (22)
Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. (2008) (21)
Third-Generation Balloon and Self-Expandable Valves for Aortic Stenosis in Large and Extra-Large Aortic Annuli From the TAVR-LARGE Registry (2020) (21)
Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality? (2010) (21)
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
One-year clinical outcome after minimally invasive direct coronary artery bypass. (2000) (21)
Novel site‐specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model (2005) (21)
Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model. (2003) (20)
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). (2010) (20)
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement. (2021) (20)
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). (2003) (20)
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. (2019) (20)
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. (2001) (20)
Angiographic evolution of intracoronary thrombus and dissection following percutaneous transluminal coronary angioplasty (the Thrombolysis and Angioplasty in Unstable Angina [TAUSA] trial). (1997) (20)
Use of a pneumatic compression system (FemoStop) as a treatment option for femoral artery pseudoaneurysms after percutaneous cardiac procedures. (1996) (20)
Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug‐eluting stent implantations (2018) (19)
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. (2018) (19)
Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts. (2006) (19)
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. (2018) (19)
The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub‐analysis of the BRAVO study (2014) (19)
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (19)
Comparison of Local Versus General Anesthesia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry). (2019) (19)
Leukocyte Count Is a Modulating Factor for the Mortality Benefit of Bivalirudin in ST-Segment–Elevation Acute Myocardial Infarction: The HORIZONS-AMI Trial (2013) (19)
Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). (2013) (19)
Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization. (1999) (19)
Types of myocardial injury and mid-term outcomes in patients with COVID-19. (2021) (18)
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%. (2003) (18)
Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention. (2003) (18)
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. (2017) (18)
How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes? (2011) (18)
Valvular Heart Disease in Women, Differential Remodeling, and Response to New Therapies (2017) (18)
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis. (2021) (18)
Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing. (2003) (17)
Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. (2003) (17)
Culprit-lesion only versus complete multivessel percutaneous intervention in ST-elevation myocardial infarction: A systematic review and meta-analysis of randomized trials. (2016) (17)
Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). (2008) (17)
Coronary artery stenting (2002) (17)
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). (2016) (17)
3D reconstruction of coronary artery bifurcations from coronary angiography and optical coherence tomography: feasibility, validation, and reproducibility (2020) (17)
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation. (2020) (17)
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial). (2019) (17)
Late Stent Thrombosis: The Last Remaining Obstacle in Coronary Interventional Therapy (2012) (17)
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. (2021) (16)
Evolution of intravascular assessment of coronary anatomy and physiology: from ultrasound imaging to optical and flow assessment (2013) (16)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis (2016) (16)
Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. (2001) (16)
The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications (2016) (16)
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention (2018) (16)
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts. (2000) (16)
Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). (2013) (15)
Factors Affecting Bleeding and Stent Thrombosis in Clinical Trials Comparing Bivalirudin With Heparin During Percutaneous Coronary Intervention (2015) (15)
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease (2021) (15)
Abstract 13371: Frequency and Clinical Impact of Nuisance Bleeding Among Patients Receiving Aspirin and Clopidogrel: Insights from the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (2011) (15)
Prognostic Significance of Cardiac Amyloidosis in Patients With Aortic Stenosis: A Systematic Review and Meta-Analysis. (2020) (15)
Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. (2006) (15)
Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study. (2014) (15)
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. (2021) (15)
Prognostic value of post-procedural aPTT in patients with ST-elevation myocardial infarction treated with primary PCI (2013) (15)
Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model. (2003) (15)
Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. (2003) (15)
Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction (2013) (14)
Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials (2016) (14)
Thrombosis after implantation of drug-eluting stents. (2006) (14)
Percutaneous transcatheter management of giant coronary aneurysms. (1999) (14)
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial (2022) (14)
Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. (2003) (14)
Patient-specific computational simulation of coronary artery bifurcation stenting (2021) (14)
Angina pectoris in Severe Aortic Stenosis (2000) (14)
Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture. (2006) (14)
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
Open Versus Endovascular Stent Graft Repair of Abdominal Aortic Aneurysms (2014) (14)
Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy (2011) (13)
Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization (2021) (13)
Primary percutaneous coronary intervention in octogenarians: navigate with caution (2010) (13)
Efficacy and safety of routine thrombus aspiration in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An updated systematic review and meta‐analysis of randomized controlled trials (2016) (13)
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry (2016) (13)
Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study). (2005) (13)
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. (2018) (13)
Editorial comment--Hypotension after carotid revascularization. (2003) (13)
Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers. (2002) (13)
Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials. (2018) (13)
Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions. (2020) (12)
Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. (2000) (12)
Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients. (2004) (12)
Ischemia‐reperfusion injury and ischemic post‐conditioning in acute myocardial infarction: Lost in translation (2017) (12)
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry (2018) (12)
Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions: Observational, Propensity-Matched Analysis From the Premier Hospital Database (2016) (12)
Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX. (2011) (12)
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention: Insights From the PARIS Registry (2019) (12)
Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. (2017) (12)
Art and Science of Cerebrovascular Event Prevention After Transcatheter Aortic Valve Replacement. (2016) (12)
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy). (2005) (11)
Randomized trial of rotational atherectomy vs balloon angioplasty for in-stent restenosis (ROSTER) (1998) (11)
Impact of insulin treated and non‐insulin‐treated diabetes compared to patients without diabetes on 1‐year outcomes following contemporary PCI (2020) (11)
Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention: An Updated Meta-Analysis of Randomized Controlled Trials (2018) (11)
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions. (2003) (11)
Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association (2021) (11)
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols. (2018) (11)
Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization (2013) (11)
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement (2020) (11)
Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound. (2004) (11)
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention (2022) (11)
Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. (2014) (11)
Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia. (2004) (11)
Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model. (2002) (11)
Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease. (2015) (11)
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
Recertification in interventional cardiology. (2008) (11)
Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. (2022) (11)
Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry (2020) (10)
Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems. (2010) (10)
Erratum: Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. J Am Coll Cardiol Intv 2011;4:97481 (2011) (10)
Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. (2015) (10)
Incidence, predictors, and economic impact of contrast induced nephropathy: results in 8,628 patients treated with percutaneous coronary interventions (2002) (10)
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents (2008) (10)
Non-Q-wave infarction and ostial left coronary obstruction due to giant Lambl's excrescences of the aortic valve. (1999) (10)
Facilitated/Pharmaco-invasive Approaches in STEMI (2012) (10)
Intra-arterial reteplase for the treatment of acute limb ischemia. (1999) (10)
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. (2017) (10)
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis (2018) (10)
Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review (2020) (10)
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. (2010) (10)
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). (2017) (10)
Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention. (2017) (10)
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis. (2021) (10)
Composite outcomes in coronary bypass surgery versus percutaneous intervention. (2014) (9)
One‐year results of the ICON (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study (2016) (9)
Prediction, staging, and outcomes of ischaemic cardiogenic shock after STEMI: a complex clinical interplay (2018) (9)
Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention (2009) (9)
Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes. (2015) (9)
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention (2019) (9)
Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). (2012) (9)
Intravascular Ultrasound—Guided Renal Artery Stenting (2001) (9)
TCT-446 Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Elderly Patients (≥75 years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry (2012) (9)
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents. (2020) (9)
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction (2021) (9)
Interventional therapy for acute myocardial infarction: respect the microvasculature. (2003) (9)
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial (2017) (9)
Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complication. (2003) (9)
Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial). (2011) (8)
Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry. (2021) (8)
Temporal trends, determinants, and impact of high‐intensity statin prescriptions after percutaneous coronary intervention: Results from a large single‐center prospective registry (2019) (8)
Bleeding After Aortic Valve Replacement Matters: Important Mortality Risk. (2017) (8)
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial. (2019) (8)
Contrast-Associated Acute Kidney Injury. Reply. (2019) (8)
Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial (2012) (8)
Optimally deployed stents in the treatment of restenotic versus de novo lesions. (2000) (8)
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials. (2018) (8)
Normal to normal: a method of treatment of coronary aneurysms with deployment of bare-metal stents. (2011) (8)
Interventional procedures in acute myocardial infarction. (2001) (8)
A sex paradox in clinical outcomes following complex percutaneous coronary intervention. (2020) (8)
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. (2021) (8)
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. (2022) (8)
Sex‐based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO‐3 randomized trial (2017) (8)
Prediction of 1‐year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient‐level pooled analysis from three randomized trials (2016) (8)
DOES AGGRESSIVE STATIN THERAPY REDUCE CORONARY ATHEROSCLEROTIC PLAQUE LIPID CONTENT? RESULTS FROM: REDUCTION IN YELLOW PLAQUE BY AGGRESSIVE LIPID LOWERING THERAPY (YELLOW) TRIAL (2012) (8)
Common pathways for primary hypertrophic and dilated cardiomyopathy. (2003) (8)
Aspirin, Platelet P2Y12 Receptor Inhibitors, and Other Oral Antiplatelets: Comparative Pharmacology and Role in Elective PCI. (2013) (8)
Revascularization of unprotected left main coronary artery disease: Strategy selection and systematic risk assessment (2012) (8)
Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin. (2016) (8)
Stroke prevention in valvular heart disease: from the procedure to long-term management. (2015) (8)
Association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease. (2016) (7)
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. (2019) (7)
2009 Focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology. (2010) (7)
ascular Complications Associated With rteriotomy Closure Devices in Patients ndergoing Percutaneous Coronary Procedures (2016) (7)
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry (2020) (7)
Impact of stent diameter on outcomes following percutaneous coronary intervention with second‐generation drug‐eluting stents: Results from a large single‐center registry (2019) (7)
Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. (2015) (7)
Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials. (2016) (7)
Changing concepts in the determination of valvular stenosis. (1997) (7)
Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial. (2019) (7)
Premature coronary artery disease in systemic lupus erythematosus with extensive reocclusion following coronary artery bypass surgery. (2003) (7)
Temporal trends of survival and utilization of mechanical circulatory support devices in patients with in‐hospital cardiac arrest secondary to ventricular tachycardia/ventricular fibrillation (2019) (7)
Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes (2007) (7)
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease (2018) (7)
Neuroprotection reduces the risk of peri-procedural major strokes and death in octogenarians (2002) (7)
Safety issues related to treating bifurcation lesions. (2010) (6)
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes The (2019) (6)
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (6)
Sirolimus-coated Stent Prevents Neointimal Proliferation. (2001) (6)
The effect of early postinfarction revascularization of asymptomatic patients on left ventricular remodeling. (1999) (6)
Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy (2013) (6)
Aortic Stenosis With Severe Asymmetric Septal Hypertrophy: A Novel Management Strategy to Improve TAVR Outcomes. (2019) (6)
Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy. (2003) (6)
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes. (2016) (6)
Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration. (2019) (6)
Pathophysiology and Management of Heart Failure (1999) (6)
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. (2023) (6)
Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis. (2018) (6)
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2019) (6)
TAVR for Severe Aortic Regurgitation: Advancing the Frontier. (2017) (6)
Stent implantation neutralizes the impact of preintervention arterial remodeling on subsequent target lesion revascularization. (2000) (6)
Outcomes of patients undergoing elective percutaneous coronary interventions in the ambulatory versus in-hospital setting. (2014) (5)
Sunday, 26 August 2012 (2012) (5)
Significant radiation reduction in interventional fluoroscopy using a novel eye controlled movable region of interest. (2016) (5)
Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study. (2021) (5)
Three dimensional reconstruction of coronary artery stents from optical coherence tomography: experimental validation and clinical feasibility (2021) (5)
Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial (2017) (5)
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI (2021) (5)
Safety and efficacy of the bioabsorbable polymer everolimus‐eluting stent versus durable polymer drug‐eluting stents in high‐risk patients undergoing PCI: TWILIGHT‐SYNERGY (2020) (5)
Anatomic classification of mitral annular calcification for surgical and transcatheter mitral valve replacement (2021) (5)
Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry). (2011) (5)
Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry. (2015) (5)
IMPACT OF CLOPIDOGREL ON-TREATMENT PLATELET REACTIVITY ON STENT THROMBOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A COLLABORATIVE META-ANALYSIS OF INDIVIDUAL PARTICIPANT DATA (2011) (5)
Trends and Outcomes of Intravascular Imaging-guided Percutaneous Coronary Intervention in the United States (2019) (5)
Histopathological Correlates of Early Arterial Recoil following Directional Coronary Atherectomy (1998) (5)
Percutaneous revascularization of left main (2012) (5)
Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial. (2020) (5)
Handbook of chronic total occlusions (2008) (5)
Primary mechanical reperfusion in acute myocardial infarction: the United States experience. (1999) (5)
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. (2007) (5)
Relation between preintervention remodeling and late arterial responses to coronary angioplasty or atherectomy. (2001) (5)
Transcatheter aortic valve implantation: lessons from the PARTNER (Placement of Aortic Transcatheter Valves) trial. (2011) (5)
Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. (2014) (5)
American College of Cardiology Annual Scientific Session 2010: update in interventional cardiology. (2010) (5)
Cerebrovascular Events After a Primary Percutaneous Coronary Intervention Strategy for Acute ST-Segment– Elevation Myocardial Infarction: Analysis From the HORIZONS-AMI Trial (2015) (5)
Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction. (2015) (5)
Interventional cardiology : principles and practice (2011) (5)
Adjunct Pharmacotherapy After Transcatheter Aortic Valve Replacement: Current Status and Future Directions. (2019) (5)
Renal Artery Stenosis: Diagnosis and Management (2002) (5)
Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study. (2014) (4)
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (4)
Myocardial damage after TAVR assessed with CMR: a new piece in a puzzle? (2014) (4)
Second-generation drug-eluting stents and bioresorbable vascular scaffolds in patients with diabetes. (2014) (4)
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial (2021) (4)
Transfemoral PCI skill: Use it or lose it.….But #RadialFirst (2018) (4)
Antegrade, Retrograde, and Combination Strategies for Chronic Total Occlusions (2010) (4)
Have the outcomes of rescue angioplasty after failed thrombolytic therapy in acute myocardial infarction improved in the stent era (2002) (4)
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial (2019) (4)
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI (2022) (4)
Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta‐analysis (2022) (4)
Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantation (2021) (4)
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study (2020) (4)
Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions. (2004) (4)
Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single‐center registry study (2020) (4)
Is surgery preferred for the diabetic with multivessel disease? Debate on revascularization strategy for diabetic patients with multivessel coronary artery disease. (2005) (4)
Coronary Artery Stents (1999) (4)
Noncontrast Nephropathy After Percutaneous Mitral Valve Edge-to-Edge Repair. (2020) (4)
Revascularization of a chronically occluded left anterior descending artery: is it worth all the effort? (2008) (4)
Diabetes mellitus and multivessel coronary artery disease: an ongoing battle for an ideal treatment strategy. (2017) (4)
Future stent drug delivery systems. (2008) (4)
Cusp Overlap Technique: Should It Become the Standard Implantation Technique for Self-expanding Valves? (2021) (4)
Percutaneous Coronary Intervention Outcomes in Very Elderly Patients From a Single Large-Volume Tertiary Care Center, Specifically Focusing on Nonagenarians. (2017) (4)
Multivessel Disease: Percutaneous Coronary Intervention for Classic Coronary Artery Bypass Grafting Indications (2008) (4)
The end of systemic anticoagulation therapy for restenosis prevention. (2001) (4)
Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin: PATENS Trial. (2022) (4)
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age. (2003) (4)
Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI. (2020) (4)
Drug-Eluting Stents in the Treatment of Intermediate Lesions (2006) (4)
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. (2009) (4)
Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial. (2016) (3)
IMPACT OF EJECTION FRACTION ON MORTALITY IN PATIENTS UNDERGOING PCI: A PATIENT-LEVEL POOLED ANALYSIS FROM THE REPLACE-2, ACUITY AND HORIZONS-AMI TRIALS (2012) (3)
Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry. (2020) (3)
Small proximal vessels are not always small: an intravascular ultrasound study (2002) (3)
Novel Predictors of New Persistent Left Bundle Branch Block After SAPIEN 3 Transcatheter Aortic Valve Replacement. (2020) (3)
Impact of sex on long‐term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes (2021) (3)
Monday, 27 August 2012 (2012) (3)
IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER CORONARY ANGIOGRAPHY OR PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A POOLED ANALYSIS FROM THE HORIZONS-AMI AND ACUITY TRIALS (2014) (3)
Angiographic in-stent restenosis patten predicts outcome after gamma vascular brachytherapy (2003) (3)
Management of acute myocardial injury in patients with confirmed or suspected COVID-19 (2020) (3)
The radiance P-32 RDX balloon in saphenous vein grafts: A comparison of De-Novo and In-Stent restenotic lesions in the SVG brite trial (2003) (3)
How to diagnose, how to treat: renal artery stenosis-diagnosis and management. (2002) (3)
Endothelial progenitor cells in coronary atherosclerosis and percutaneous coronary intervention: A systematic review and meta-analysis. (2022) (3)
Selection of the Optimal Candidate to MitraClip for Secondary Mitral Regurgitation: Beyond Mitral Valve Morphology (2021) (3)
IMPACT OF PLATELET REACTIVITY ON CLINICAL OUTCOMES: A PATIENT LEVEL META-ANALYSIS (2010) (3)
Abstract 20882: Predictors of Suboptimal TIMI Flow after Primary Angioplasty for Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (3)
Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation. (2022) (3)
Transpulmonary electrotherapy for reduction of lung viral load of SARS-CoV-2 in patients with COVID-19 (2020) (3)
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. (2022) (3)
Sex differences in 1‐year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration (2020) (3)
Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement: Additional Data, Yet Still Many Unanswered Questions. (2022) (3)
Outcomes from carotid artery stenting in over 1,000 cases from a single group of operators (2003) (3)
Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions (2006) (3)
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. (2014) (3)
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial (2017) (3)
PCI options in heparin-induced thrombocytopenia. (2003) (3)
Clinical Impact of Enhanced Inhibition of P2Y12-Mediated Platelet Aggregation in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (2010) (3)
Correlates and Impact of Coronary Artery Calci ﬁ cations in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (3)
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI (2021) (3)
Prasugrel in NSTEMI: loading after seeing. (2014) (3)
Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial. (2020) (3)
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy (2022) (3)
Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention. (2019) (3)
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry). (2020) (3)
Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study (2016) (3)
1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration. (2020) (3)
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry (2021) (3)
Off-label use of drug-eluting stents: assessing the risk (2007) (3)
PROGNOSTIC IMPACT OF STAGED VERSUS "ONE-TIME" MULTIVESSEL PCI IN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: LONG-TERM ANALYSIS FROM THE HORIZONS-AMI TRIAL (2011) (3)
Abstract 2518: Clinical and Angiographic Outcomes after Percutaneous Revascularization of Chronic Total Occlusions with Bare-Metal and Drug-Eluting Stents: 3-year Follow-up Results from an International Multicenter CTO Registry (2008) (3)
Monday, 27 August 2012 (2012) (3)
Comparison of Transaortic and Subclavian Approaches for Transcatheter Aortic Valve Replacement in Patients with No Transfemoral Access Options (2018) (3)
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry (2019) (3)
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort (2021) (3)
Human immunodeficiency virus infection and high c-reactive protein correlates with increased in-stent restenosis rate (2003) (3)
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply. (2020) (3)
3D Reconstruction of Coronary Artery Stents From Optical Coherence Tomography: Experimental Validation and Clinical Feasibility (2021) (2)
Impact of diabetes on coronary remodeling in patients with acute coronary syndromes: An intravascular ultrasound study (2003) (2)
COMPARISON OF BLEEDING DEFINITIONS, BARC, GUSTO, TIMI AND VARC IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A TWO-CENTER REGISTRY (2012) (2)
Cardiac biomarkers for the prediction and diagnosis of atherosclerotic disease and its complications. (2006) (2)
Novel Drug Eluting Stent Systems (2011) (2)
Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial (2022) (2)
Favorable effect of γ‐radiation for in‐stent restenosis: Effect of diabetes on angiographic and clinical outcomes (2004) (2)
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom (2022) (2)
EVEN AFTER PERCUTANEOUS CORONARY INTERVENTION OF ANGIOGRAPHICALLY SIGNIFICANT LESIONS, IVUS-DEFINED HIGH-GRADE STENOSES ARE COMMON. A BASELINE IVUS ANALYSIS FROM THE PROSPECT TRIAL (2010) (2)
MaXIMAl benefits in the elderly? (2014) (2)
Subtotal Occlusion of Left Anterior Coronary Artery in a Professional Athlete (2018) (2)
Maintenance of certification in interventional cardiology revisited. (2010) (2)
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization (2016) (2)
What to do when a patient with coronary stents needs surgery? (2014) (2)
Stent thrombosis and restenosis (2017) (2)
WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
INCIDENCE, PREDICTORS AND IMPACT OF STROKE IN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE ACUITY TRIAL (2012) (2)
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration (2021) (2)
Endovascular Interventions (2018) (2)
Coronary Artery Dissections, Perforations, and the No‐Reflow Phenomenon (2016) (2)
Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study. (2014) (2)
Restenosis following percutaneous coronary interventions: a clinicalproblem (2005) (2)
Cardiac enzyme elevation after coronary revascularization (2018) (2)
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank (2021) (2)
Abstract 5608: Prognostic Impact of the Baseline White Blood Cell Count in Patients with Acute Myocardial Infarction Undergoing Primary PCI: Results from the HORIZONS-AMI trial (2008) (2)
COMPLIANCE WITH DUAL ANTIPLATELET THERAPY AND SUBSEQUENT ADVERSE EVENTS IN PATIENTS WITH STEMI UNDERGOING STENT IMPLANTATION: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2010) (2)
Deploying a Novel Custom Mobile Application for STEMI Activation and Transfer in a Large Healthcare System to Improve Cross-Team Workflow. STEMIcathAID Implementation Project. (2022) (2)
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry). (2022) (2)
IMPACT OF INITIAL EVOLUT TAVR DEPLOYMENT ORIENTATION ON FINAL VALVE ORIENTATION AND CORONARY REACCESS: A PILOT STUDY (2019) (2)
Gamma radiation for in‐stent restenosis: effect of lesion length on angiographic and clinical outcomes (2004) (2)
2349Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients (2019) (2)
Prosthesis-Patient Mismatch Between Transcatheter Heart Valves in TAVR Using a Computed Tomography-Derived Comparative Model. (2020) (2)
A Comparison of Tirofiban and Abciximab in Patients Undergoing Coronary Stent Implantation: Rationale, Design, and Results of the TARGET Trial. (2001) (2)
Intracoronary Ultrasound for Optimizing Stent Implantation (2010) (2)
Abstract 15919: Impact of Bivalirudin Therapy on Mortality in Patients With High Risk Features Undergoing PCI: A Patient-Level Pooled Analysis From the REPLACE-2, ACUITY and HORIZONS-AMI Trials (2011) (2)
Prospective evaluation of a stiff shaft glide wire compared with the standard straight wire in crossing severely stenotic aortic valves. (1997) (2)
TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation. (2016) (2)
Subacute Aortic Root and Valve Thrombosis following Transcatheter Aortic Valve Replacement in a Left Ventricular Assist Device Patient: From One Problem to the Next (2021) (2)
Early Stent Thrombosis after Percutaneous Coronary Intervention for Acute Myocardial Infarction (2011) (2)
Procedural and Long-Term Clinical Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions in Women: A Report From the Multinational Cto Registry (2011) (2)
Clopidogrel loading dose pre-PCI: how high? (2004) (2)
EFFECT OF THROMBOTIC AND BLEEDING RISK ACCORDING TO PLATELET REACTIVITY ON 2-YEAR MORTALITY: THE ADAPT-DES STUDY (2017) (2)
Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography. (2000) (2)
On the Pathogenesis of Unstable Angina 1997 (1997) (2)
Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century. (2001) (2)
PHYSIOLOGIC IMPACT OF CHRONIC KIDNEY DISEASE ON WHOLE BLOOD CLOT KINETICS AND STRENGTH (2012) (2)
Effect of Chronic Kidney Disease in WomenUndergoing Percutaneous CoronaryIntervention With Drug-ElutingStents (2)
Two years into the COVID-19 pandemic: implications for the cardiac catheterization laboratory and its current practices (2022) (2)
A Biomarker‐Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy (2022) (2)
Coronary chronic total occlusions: How to dilate the tough ones (2018) (2)
Urgent Interventional Therapies (2014) (2)
Mobile application to optimize care for ST-segment elevation myocardial infarction patients in a large healthcare system, STEMIcathAID: rationale and design (2021) (2)
FEASIBILITY OF REPEAT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AFTER SAPIEN 3 TAVR (TAV-IN-TAV): A PILOT ANGIOGRAPHIC STUDY (2019) (2)
3 YEAR OUTCOMES OF TRANSCATHETER MITRAL VALVE-IN-VALVE, VALVE-IN-RING AND VALVEIN-MITRAL ANNULAR CALCIFICATION: RESULTS FROM THE MITRAL TRIAL (2022) (2)
Exercise physiology in the catheterization laboratory: still alive and well! (2012) (2)
291 Ticagrelor monotherapy after percutaneous coronary intervention in high-risk patients with prior myocardial infarction: a prespecified twilight substudy (2021) (1)
WHICH GLOMERULAR FILTRATION RATE EQUATION BEST PREDICTS POOR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI: RESULTS FROM THE HORIZONS-AMI STUDY (2012) (1)
Different mechanism of lumen enlargement during balloon angioplasty between focal and diffuse in-stent restenosis (2002) (1)
IMPACT OF STENT DIAMETER ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2018) (1)
A single-step stent delivery, deployment, and expansion system. (1997) (1)
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial (2020) (1)
Physiological correlates of densely calcified coronary lesions on coronary computed tomography angiography among patients with low-to-intermediate coronary artery disease likelihood (2011) (1)
SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 Registry (2023) (1)
Acute myocardial infarction and multivessel disease: some vessels are more equal than others (2010) (1)
IMPACT OF MEMBRANOUS SEPTAL LENGTH ON NEW PERMANENT PACEMAKER IMPLANTATION AFTER SAPIEN 3 TAVR (2020) (1)
A NOVEL TECHNIQUE FOR QUANTIFYING MAC IN THE ERA OF TRANSCATHETER MITRAL TECHNIQUES (2019) (1)
IMPACT OF BIVALIRUDIN ON ACCESS AND NON-ACCESS RELATED BLEEDING IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER REGISTRY (2012) (1)
Abstract 4452: What are the Reasons for Clopidogrel Discontinuation after PCI? (2008) (1)
Balloon Dilatation of Expandable Sheath to Facilitate Transfemoral SAPIEN 3 Transcatheter Aortic Valve Replacement in Severely Calcified Vasculature (2022) (1)
Bioresorbable Vascular Scaffolds in Women. (2017) (1)
Prognostic importance of myonecrosis after percutaneous coronary interventions. (2001) (1)
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration. (2020) (1)
Stenting with abciximab (ReoPro™) decreases target lesion revascularization (1998) (1)
Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria (2021) (1)
Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary intervention (2001) (1)
Comparison of gated Tc99m-MIBI SPECT with Tc99m-MIBI/F18-FDG SPECT imaging in the diagnosis of resting ischemia, scarring, and viability (1996) (1)
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative (2020) (1)
Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI. (2022) (1)
Why females get better longer‐term outcomes with TAVR (2019) (1)
INCIDENCE OF ACUTE KIDNEY INJURY WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (1)
TCT-447 Real World Generalizability Of Patients Enrolled In Clinical Trials Versus Those Not Enrolled (2015) (1)
Evaluation of Cerebral Thromboembolism After Transcatheter Aortic Valve Replacement (EARTH TAVR): A Serial Magnetic Resonance Imaging Evaluation as Substudy of the GALILEO Trial. (2021) (1)
The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures. (1999) (1)
percutaneous coronary intervention: Development and initial validation A simple risk score for prediction of contrast-induced nephropathy after (2009) (1)
Society for Cardiovascular Angiography and Interventions 2010 and EuroPCR 2010: an update in interventional cardiology. (2010) (1)
Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes. (2004) (1)
Current Concepts of Pathogenesis and Treatment (2016) (1)
IMPROVED PHARMACOLOGIC PROFILE OF A NOVEL, LIQUID ASPIRIN FORMULATION COMPARED WITH ENTERIC COATED ASPIRIN-A POOLED, PATIENT LEVEL ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES (2020) (1)
Tuesday, 28 August 2012 (2012) (1)
Impact of vessel size after coronary vascular brachytherapy: a report of 990 patients (2002) (1)
Can Coronary Stent Implantation Complexity Become an Intuitive and Useful Factor to Tailor DAPT Duration? (2016) (1)
The quest for a “diabetic” stent (2018) (1)
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis. (2022) (1)
Procedural and technical complications (2007) (1)
TAVR for aortic regurgitation: Not as straightforward! (2021) (1)
Abstract 1715: Necrotic Core and its Ratio to Dense Calcium are Predictors of High-risk Non-ST-Elevation Acute Coronary Syndromes: Results from the Prospective, Multi-center, Global VH-IVUS Registry (2007) (1)
TRENDS IN INCIDENCE AND MORTALITY ASSOCIATED WITH ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PCI FOR ACUTE CORONARY SYNDROME (2017) (1)
Carotid Artery Stenting in Patients with High-Risk Anatomy for Carotid Endarterectomy (2001) (1)
Abstract 17531: Two-Year Clinical Results Comparing Abciximab vs. Eptifibatide in Combination With 600mg vs. 300mg Clopidogrel Loading Dose in Patients With ST-Elevation Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (1)
Peripheral CTO recanalization and revascularization techniques (2007) (1)
The quest for the optimal treatment for in‐stent restenosis (2018) (1)
Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era. (2017) (1)
Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index. (2022) (1)
Oral rapamycin for the prevention of in-stent restenosis (2003) (1)
Bioprosthetic Valve Thrombosis: Insights from Transcatheter and Surgical Implants (2020) (1)
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort. (2022) (1)
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing PCI. (2022) (1)
Thrombus aspiration in primary percutaneous coronary intervention how to manage failure. (2011) (1)
Takotsubo cardiomyopathy mimics an acute coronary syndrome in postmenopausal women. (2009) (1)
Dual Antiplatelet Therapy Following PCI for NSTEMI: An Obvious Choice or a Calculated Decision? (2020) (1)
Directional Coronary Atherectomy in Acute Myocardial Infarction (1998) (1)
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. (2022) (1)
CLINICAL UTILITY OF BIOMARKERS TO PREDICT STENT THROMBOSIS AFTER STEMI TREATED WITH DES: A HORIZONS-AMI SUBSTUDY WITH 3-YEAR FOLLOW-UP (2011) (1)
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. (2021) (1)
DIFFERENCES IN CORONARY PLAQUE COMPOSITION AND MORPHOLOGY IN PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE PRESENTING WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT STUDY (2011) (1)
IMPACT OF WEIGHT ON THE ANTIPLATELET EFFECTS OF ASPIRIN-RESULTS OF A POOLED ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES COMPARING A LIQUID ASPIRIN FORMULATION WITH ENTERIC COATED ASPIRIN (2020) (1)
Chronic kidney disease is associated with increased mortality, bleeding, and ischemic events in moderate and high-risk patients with acute coronary syndromes: An ACUITY substudy (2007) (1)
Percutaneous Coronary Intervention of Arterial and Vein Grafts (2016) (1)
IMPACT OF CHRONIC KIDNEY DISEASE ON LONG-TERM OUTCOMES IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND ALTERNATIVE ANTITHROMBOTIC TREATMENT STRATEGIES: A HORIZONS-AMI SUBSTUDY (2011) (1)
HIGH BLEEDING RISK AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT OF RACE/ETHNICITY (2020) (1)
TCT CONNECT-218 Transcatheter Therapies For COVID-19 (2020) (1)
Cardioprotective effect of beta-blocker therapy in reducing CK-MB release after coronary intervention (1999) (1)
ARE VULNERABLE PLAQUES WIDELY DISSEMINATED OR FOCAL? A BASELINE 3-VESSEL IVUS ANALYSIS FROM THE PROSPECT TRIAL (2010) (1)
Impact of anemia on short‐term outcomes after TAVR: A subgroup analysis from the BRAVO‐3 randomized trial (2021) (1)
IMPACT OF CHRONIC KIDNEY DISEASE ON MYOCARDIAL BLUSH AND ST-SEGMENT RESOLUTION FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE HORIZONS-AMI TRIAL (2012) (1)
P6114Characteristics and clinical outcomes in patients undergoing PCI by levels of high-density lipoproteins (2017) (1)
Assessment of trans‐aortic pressure gradient using a coronary pressure wire in patients with mechanical aortic and mitral valve prostheses (2018) (1)
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft (2021) (1)
QUANTIFICATION AND IMPACT OF UNTREATED CORONARY ARTERY DISEASE AFTER PCI: THE RESIDUAL SYNTAX SCORE (2012) (1)
SGLT-2 inhibitors in patients with and without a history of heart failure: a meta-analysis (2021) (1)
COMPARING PCI OUTCOMES IN THE VERY ELDERLY: DOES AGE MATTER? A REPORT FROM OUTCOMES OF SEPTUAGENARIANS, OCTOGENARIANS AND NONAGENARIANS AFTER PCI (2017) (1)
Dual Antiplatelet Therapy Duration: A Review of Current Available Evidence. (2016) (1)
Intravascular ultrasound predictors of late recurrence after stent implantation in small coronary arteries (2003) (1)
Interventional Pharmacology. (2013) (1)
MKL1 C–184>T AND CYP3A5 A–6986>G POLYMORPHISMS ARE ASSOCIATED WITH CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER PCI (2013) (1)
SYNERGISTIC IMPACT OF CORONARY CALCIFICATION AND BIFURCATION TARGET LESIONS ON ADVERSE CARDIOVASCULAR EVENTS FOLLOWING PCI: INSIGHTS FROM A LARGE SINGLE-CENTER PCI REGISTRY (2019) (1)
TCT-68 Influence of Final Kissing Balloon Inflation on Long-Term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial (2019) (1)
Outcomes and feasibility of redo‐TAVR after Sapien 3 Ultra TAVR in extremely‐undersized versus nominally‐sized annuli (2022) (1)
TCT-482 "Resistant" In-Stent Restenosis in the Drug-Eluting Stent Era: An Angiographic Description and Outcomes (2013) (1)
Treatment of hypercholesterolemic patients with and without coronary disease with pravastatin decreases thrombus formation under dynamic flow conditions (1998) (1)
Real dilemmas regarding blood transfusion. (2015) (1)
26. Microembolic Risk of Carotid Artery Plaque Composition By MRI at the Time of Elective Revascularization (2015) (1)
PREDICTORS OF MAJOR BLEEDING POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (1)
Trans-epicardial transplantation of mature endothelial cells induces neoangiogenesis and improves LV function in an animal model of ischemic cardiomyopathy (2002) (1)
Impact of the ACUITY and TIMI major bleeding definitions on one-year mortality in patients with acute coronary syndromes (2007) (1)
Intraprocedural Mapping of the Mitral Calcium for Positioning and Deployment of Transcatheter Valve-in-Mitral Annular Calcification. (2022) (1)
TCT-67 Impact of Hemodynamic Support With Impella vs Intraaortic Balloon Counterpulsation on Prognostically Important Ischemic Endpoints: Results from the PROTECT-II Trial (2012) (1)
[Dynamic nature of coronary plaques and clinical outcomes in diabetic patients: is change in itself bad?]. (2011) (1)
Coronary Artery Dissection and Perforation (2011) (1)
The HEP@NET study: an internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation (2002) (1)
Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention. (2022) (1)
MAJOR VASCULAR COMPLICATIONS IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (1)
IMPACT OF RESIDUAL INFLAMMATORY RISK IN PATIENTS WITH LOW LDL-CHOLESTEROL UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHT FROM A LARGE SINGLE-CENTER REGISTRY (2019) (1)
Post-TAVR coronary obstruction (2015) (1)
Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions (2014) (1)
Prevalence and prognostic impact of hsCRP elevation are age‐dependent in women but not in men undergoing percutaneous coronary intervention (2020) (1)
Bivalirudin or Heparin Treatment During Transcatheter Valve Interventions: Where are we Now? (2016) (1)
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. (2022) (1)
Contemporary Concepts in Cardiology (1999) (1)
TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (1)
1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry (2020) (1)
Interventional Pharmacology: Stent-Based Drug Delivery, Local Drug Delivery Management of Patients Before and After PCI (2014) (1)
TCT CONNECT-307 Long-Term Outcomes After Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis According to Diabetes Mellitus Status (2020) (1)
CHARACTERIZING AND QUANTIFYING MITRAL ANNULAR CALCIFICATION FOR PATIENT-PREDICTIVE MODELING IN THE ERA OF TMVR (2020) (1)
TCT-288 Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis. (2016) (1)
Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD. (2002) (1)
Gender differences in clinical outcomes after percutaneous coronary intervention in small coronary arteries (2002) (1)
Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients　- A Subanalysis of the ENVISAGE-TAVI AF Trial. (2022) (1)
Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease (2023) (1)
The optimal pharmacological formula for percutaneous coronary intervention (2011) (1)
In‐stent restenosis of bifurcation lesions: Experience with drug‐eluting balloons (2012) (1)
Direct stenting improves target lesion revascularization in saphenous vein graft lesions: an intravascular ultrasound-guided study (2002) (1)
Are small vessels "truly" small? (2000) (1)
Cardiovascular interventional pharmacology in the diabetic patient (2007) (0)
Impact of high-density lipoprotein levels in males and females undergoing percutaneous coronary intervention with drug eluting stents (2020) (0)
P1389Impact of peripheral arterial disease on provision of discharge pharmacotherapy and longitudinal outcomes in patients with stable angina undergoing percutaneous coronary interventions (2017) (0)
Reply: TAVR and Stroke Prevention: Importance of Cerebral Embolic Protection Device Data. (2017) (0)
Thrombolytic therapy in acute myocardial infarction. (1998) (0)
Major bleeding is associated with increased one-year mortality and ischemic events in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial (2007) (0)
EC 1 Prognosis of Patients with Acute Coronary Syndromes with Elevated Troponin and Patent (2012) (0)
TCT-803 Clinical Outcomes After TAVR in Patients With and Without Peripheral Arterial Disease: Results From the BRAVO-3 Randomized Trial (2019) (0)
TCT-481 Treatment of "resistant" in-stent restenosis in the drug-eluting era: comparison of repeat stent versus balloon only strategy (2013) (0)
IMPACT OF SEX ON OUTCOMES AMONG PATIENTS WITH A PREVIOUS CORONARY ARTERY BYPASS GRAFT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
Abstract WP171: Predictors and Outcomes of Stroke After Trans-Catheter Aortic Valve Replacement in the United States, 2012-2014 (2018) (0)
TCT-32 Safety and Efficacy of Biodegradable Polymer Biolimus-Eluting Stents in Patients With Non–ST-Elevation Acute Coronary Syndrome: A Pooled Analysis of GLASSY and TWILIGHT (2021) (0)
Chronic coronary total occlusions: Let's make the long story short (2021) (0)
Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data. (2021) (0)
European Society of Cardiology Congress 2009 update in interventional cardiology. (2009) (0)
TCT-260 Which is the Ideal Revascularization Strategy in Patients Presenting with Acute Coronary Syndrome and Proximal LAD Stenosis? Results from the ACUITY Study (2013) (0)
Relationship of the degree of procedural anticoagulation to outcomes after stent implantation (2002) (0)
TCT-18 Impact of Initial Evolut TAVR Deployment Orientation on Final Valve Orientation and Coronary Reaccess: A Pilot Study (2019) (0)
TCT-455 Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent (2013) (0)
Retreatment immediately after gamma radiation for in-stent restenosis results in need for target vessel revascularization beyond target lesion (2002) (0)
RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT ADVERSE ISCHEMIC AND BLEEDING EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2011) (0)
PRE-CLINICAL FINDINGS OF A NOVEL THERAPEUTIC VACCINE TO LIMIT THE PROGRESSION OF CARDIOVASCULAR DISEASE: ATHEROVAX™ (2023) (0)
TCT-597 Incidence and Trends in Bleeding and Vascular Complications Among Patients Undergoing Large-Bore Access Procedures (2022) (0)
TCT-19 The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus (2013) (0)
Structure and function of the ACC Interventional Scientific Council and Section. (2008) (0)
Low-Osmolar Versus Nonionic so-Osmolar Contrast Media to Obviate orsening Nephropathy After Angioplasty n Chronic Renal Failure Patients (0)
ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Abstract 3220: Bivalirudin Monotherapy Provides Similar One-Year Survival Compared to Heparin plus GP IIb/IIIa Inhibitors in Diabetic Patients with Acute Coronary Syndromes: Results from the Randomized ACUITY Trial (2007) (0)
P6435Impact of persistent high C-reactive protein levels on all-cause mortality in patients after percutaneous coronary interventions (2018) (0)
JACC White Papers: an avenue for interventional knowledge? (2009) (0)
TCT-471 Impact of New- versus Early-Generation Drug Eluting Stents in Women according to Age: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
Comprar Handbook of Chronic Total Occlusions | Moses Jeffrey | 9781841846248 | Informa Healthcare (2007) (0)
Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion, and More (2019) (0)
Acute angiographic and clinical results of the NIR w/SOX stent. (2002) (0)
Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study (2021) (0)
Long-term outcomes of patients with acute coronary syndromes and chronic renal insufficiency undergoing percutaneous coronary intervention and being treated with bivalirudin vs heparin plus a glycoprotein IIb/IIIa inhibitor: Results from the randomized ACUITY Trial (2007) (0)
TCT-736 Prevalence and Impact of Bleeding Determinants on Risks for out-of-hospital bleeding and coronary thrombosis in patients undergoing percutaneous coronary intervention: Results from a large single-center PCI Registry (2018) (0)
Abstract 19034: Safety and Efficacy of Non-Vitamin K Antagonist Oral Anticoagulants During Transcatheter Ablation of Atrial Fibrillation (2017) (0)
Stenting in acute myocardial infarction in patients with chronic renal failure: predictors of in-hospital and long-term outcome (2002) (0)
SYNERGISTIC IMPACT OF CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS ON PERIPHERAL VASCULAR ATHEROSCLEROTIC PLAQUE NEOVASCULARIZATION AND INFLAMMATION (2012) (0)
P2646COMBO PCI outcomes in patients categorized by baseline PARIS bleeding risk score: from the global MASCOT registry (2018) (0)
Rolling the rock uphill during left main stenting: The Sisyphus myth in percutaneous coronary intervention? (2020) (0)
Double kissing crush stenting: No pain, no gain? (2022) (0)
A COMPREHENSIVE ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DRUG-ELUTING VERSUS BARE-METAL STENTS IN ACUTE MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2011) (0)
Letter to the EditorReply from the Authors (2005) (0)
TCT-757 Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After SAPIEN 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study (2019) (0)
TEMPORAL TRENDS, DETERMINANTS AND IMPACT OF HIGH-INTENSITY LIPID LOWERING THERAPY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
Comprar Interventional Cardiology. Principles And Practice 2nd Ed. | George Dangas | 9781118976036 | Wiley (2017) (0)
A-54 | Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis (2022) (0)
INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
Predictors of radiation failure after treatment of in-stent restenosis with gamma vascular brachytherapy: pooled analysis from GAMMA I, II, and SCRIPPS III studies (2002) (0)
Abstract 5593: Long-term Follow-up of Patients with Unstable Angina Treated with Drug-Eluting Stents: Pooled Analysis from 14 Clinical Trials (2008) (0)
The Future for Transcatheter Aortic Valve Implantation (2015) (0)
Angiographic complications and post‐PCI myocardial enzyme elevation: Brave new world revisited (2010) (0)
SYNERGISTIC USE OF ROTATIONAL ATHERECTOMY AND INTRAVASCULAR LITHOTRIPSY AS A CALCIUM MODIFICATION STRATEGY IN HEAVILY CALCIFIED, LARGE CALIBER CORONARY ARTERIES (2023) (0)
Abstract 15180: Impact of the Everolimus-Eluting Stent on Stent Thrombosis According to Baseline Risk of Study Population (2011) (0)
Abstract 18908: Transcutaneous Aortic Valve Replacement - 30 Day and 1 Year Outcomes Using Conscious Sedation in Patients Stratified by STS Risk Score (2014) (0)
TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. (2016) (0)
TCT-237 Efficacy and Safety of Routine Thrombus Aspiration in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: an updated Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (0)
2927Sex-related differences in patients undergoing complex coronary interventions in the era of 2nd generation DES (2017) (0)
COMPARATIVE INCIDENCE AND COSTS ASSOCIATED WITH 30-DAY READMISSION FOR RECURRENT MI VERSUS MAJOR BLEEDING AMONG PATIENTS HOSPITALIZED WITH ACUTE MI IN THE UNITED STATES: A POPULATION-BASED COHORT STUDY (2020) (0)
P1661Evaluation of transradial versus transfemoral procedures in all-comers patients treated with the dual-therapy stent (2018) (0)
Acute Coronary Syndrome (2014) (0)
Positioning of self‐expanding transcatheter valve prostheses (2019) (0)
Transplantation of autologous endothelial cells induces angiogenesis in a sheep model of chronic ischemia (2003) (0)
Evaluation of viability of myocardium in asymptomatic patients early after infarction with perfusion/metabolism single‐photon‐emission computed tomographic imaging and dobutamine echocardiography (2000) (0)
TCT-689 Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study (2019) (0)
Abstract 2217: Impact of the ACUITY and TIMI Major Bleeding Definitions on One-Year Mortality in Patients with Acute Coronary Syndromes (2007) (0)
LONG-TERM CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC TOTAL OCCLUSIONS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: FIVE-YEAR OUTCOMES FROM A 1,791 PATIENT MULTI-NATIONAL REGISTRY (2011) (0)
Interventional procedures in acute myocardial (2001) (0)
Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided Complete Revascularization of Nonculprit Artery for ST-Elevation Myocardial Infarction. (2022) (0)
Shock indices in acute myocardial infarction (2021) (0)
Abstract 18702: Obesity Paradox in Women Undergoing Percutaneous Coronary Intervention With Drug-eluting Stents: Results From a Patient-level Pooled Analysis of Randomized Controlled Trials (2015) (0)
Efficacy of gamma vascular brachytherapy for ostial versus nonostial in stent restenotic lesions (2002) (0)
SAPIEN S3 ULTRA STENT STRUTS DEFORMATION SECONDARY TO SEVERELY CALCIFIED AND STENOSED ILIAC ARTERY (2021) (0)
TCT-468 Predictors Of Stent Thrombosis After Primary Percutaneous Coronary Intervention And Risk for 30-Day Mortality: Analysis from the HORIZONS-AMI and EUROMAX trials (2014) (0)
TCT-111 Gender Differences In The Burden Of Coronary Artery Disease In Patients With Human Immunodeficiency Virus Infection Undergoing Percutaneous Coronary Intervention (2014) (0)
Lower 30-Day Mortality after Early Stent Thrombosis with Bivalirudin vs Heparin (2014) (0)
Leave nothing behind: Promising results for coronary drug‐coated balloons in clinical practice (2019) (0)
PROGNOSTIC VALUE OF HIGH SENSITIVITY C-REACTIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2022) (0)
TCT-479 Impact of Angiographic Patterns (Focal vs. Diffuse) of Resistant In-stent Restenosis on Clinical Outcomes (2013) (0)
Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study (2022) (0)
Risk of Major Cardiovascular or Cerebrovascular Events after PCI or CABG Increased in Diabetes Mellitus Patients Receiving Insulin (2013) (0)
IMPACT OF INTRAVENOUS HEPARIN ADMINISTERED PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2010) (0)
TCT-476 Antithrombotic Therapy In Patients With Chronic Kidney Disease And Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Results From The AVIATOR Registry (2014) (0)
808-2 Creatine kinase-MB elevation after coronary stenting in lesions with ruptured plaque (2004) (0)
Antisense and ODN Transcription Factors in the Treatment of Vascular Proliferative Disease (2007) (0)
Balance of Ischemia and Bleeding in Selecting an Antithrombotic Regimen. (2013) (0)
Contrast‐associated acute kidney injury: Type may not matter (2022) (0)
Abstract 13942: Do Geographic Trends in Aspirin Discharge Dose Alter Outcomes After STEMI and Primary PCI: Results From the HORIZONS-AMI Trial (2011) (0)
EFFECT OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN IN TRANSCATHETER AORTIC VALVE REPLACEMENT WITH SELF-EXPANDING VALVES: FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (0)
Randomized clinical trial comparing a rivaroxaban-based with an antiplatelet-based strategy for cerebral embolization after TAVR (EARTH TAVR)-a magnetic resonance imaging substudy of the GALILEO trial (2020) (0)
One‐year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration (2020) (0)
Coronary artery disease burden and long-term outcomes in patients with human immune deficiency virus (HIV) undergoing percutaneous coronary intervention: results from a single-center registry (2013) (0)
TCT-474 Triple vs. Dual Antithrombotic Therapy In Patients With Atrial Fibrillation And Acute Coronary Syndromes: The AVIATOR Registry (2014) (0)
LEFT VENTRICULAR CARDIAC MECHANICS IMPROVE IN PATIENTS POST TRANSCATHETER AORTIC VALVE REPLACEMENT REGARDLESS OF BASELINE LEFT VENTRICULAR FUNCTION (2020) (0)
Live Cases - Complex and High-Risk Interventional Procedures (CHIP) (2019) (0)
P3100 | BEDSIDE Endothelial dysfunction versus early atherosclerosis: a study with high resolution imaging (2015) (0)
TCT-620 Shift Of Patient Selection For Balloon Aortic Valvuloplasty After Introduction Of Transcatheter Aortic Valve Replacement: Insights From A Single-center Registry (2015) (0)
IMPACT OF HIGH DOSE ASPIRIN IN MEN VS. WOMEN AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE HORIZONS-AMI TRIAL (2012) (0)
The ongoing dilemma of anticoagulation after TAVI: Seek quality evidence. (2022) (0)
Subintimal angioplasty in coronary CTO (2013) (0)
Carotid artery stenting 19991 (2000) (0)
Abstract 18677: The ACEF Risk Score Exhibits Superior Predictive Ability for Adverse Clinical Outcomes in Women Undergoing PCI (2012) (0)
ADDITIVE EFFECT OF MULTIPLE HIGH BLEEDING RISK CRITERIA IN PATIENTS UNDERGOING PCI (2020) (0)
Abstract 5887: Experimental Model to Evaluate Human Platelet Reactivity and Related Pharmacodynamics in Mice (2009) (0)
Urgent Interventional Therapies: Kipshidze/Urgent Interventional Therapies (2014) (0)
TCT-7: MSCT Guided Co-registration for CTO Procedures-A Pilot Feasibility Study (2016) (0)
Interventional cardiology: abstractIncreased ck-mb release is a “trade-off” for optimal stent implantation: an intravascular ultrasound study (2004) (0)
Edoxaban or Vitamin K Antagonist for Atrial Fibrillation after TAVR. Reply. (2022) (0)
IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2022) (0)
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. (2022) (0)
OC10_02 Impact of Diabetes Mellitus on Patients With Human Immunodeficiency Virus Undergoing Percutaneous Coronary Intervention: Results From a Large, Single Center Registry (2016) (0)
TCT-398 Associations Between Atrial Fibrillation and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement With Self-Expanding Devices: Results From the United States STS/ACC TVT Registry (2017) (0)
TCT-446 Outcomes Among Patients Enrolled Versus Not Enrolled In Interventional Cardiovascular Clinical Trials: Insights From A Single-center Analysis (2015) (0)
Reply: Bioresorbable Scaffold Thrombosis: A Multifactorial Phenomenon Also Involving Hypersensitivity Inflammation? (2017) (0)
NOVEL PREDICTORS OF PERSISTENT LEFT BUNDLE BRANCH BLOCK AND PERMANENT PACEMAKER IMPLANTATION AFTER EDWARDS SAPIEN 3 TAVR (2019) (0)
Diabetes mellitus in transfemoral transcatheter aortic valve implantation in 11,440 patients from the CENTER collaboration (2020) (0)
Percutaneous Coronary Intervention Early Stent Thrombosis after Percutaneous Coronary Intervention for Acute Myocardial Infarction (2012) (0)
Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial. (2023) (0)
Patient selection and general approach to CTO revascularization (2007) (0)
TCT-489 Stent Thrombosis after primary PCI for STEMI in relation to non-usage of dual antiplatelet therapy over time: Results of the HORIZONS-AMI trial (2012) (0)
TCT-566 Impact of Sex on Risk for Adverse Events Associated With Polyvascular Disease in Patients After PCI (2022) (0)
EFFICACY AND SAFETY OF FIRST GENERATION VERSUS NEWER GENERATION DRUG-ELUTING STENTS IN PATIENTS WITH DIABETES: A DIRECT COMPARISON META-ANALYSIS OF 8,438 PATIENTS FROM RANDOMIZED TRIALS (2016) (0)
THE EFFECT OF COMPLEX CORONARY REVASCULARIZATION PROCEDURE IN PATIENTS AT HIGH-BLEEDING RISK (2020) (0)
TCT-27 Ticagrelor Versus Prasugrel in an All-Comer Patient Cohort Undergoing Percutaneous Coronary Intervention (2022) (0)
IMPACT OF TROPONIN ELEVATION ON OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC RENAL INSUFFICIENCY (2010) (0)
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age vs. those <75 years of age (2004) (0)
Endovascular treatment of infrarenal aortic aneurysms (2002) (0)
TCT-150 Prognostic Value of Different Definitions of Contrast Induced Acute Kidney Injury in STEMI: Analysis from the HORIZONS-AMI Trial (2012) (0)
Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial Subanalysis (2021) (0)
The Optimal Duration of Dual Antiplatelet Therapy After PCI (2016) (0)
Different mechanism of lumen enlargement in lesions with stent underexpansion after balloon angioplasty for in-stent restenosis compared to those with optimal stent expansion: an intravascular ultrasound study (2002) (0)
INCIDENCE, PREDICTORS AND IMPACT OF MAJOR BLEEDING IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
TCT-858 Residual inflammatory status in patients with stable coronary artery disease undergoing percutaneous coronary intervention (2018) (0)
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention. (2022) (0)
TCT-838 Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index (2019) (0)
TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
NOVEL PREDICTORS OF NEW PERSISTENT LEFT BUNDLE BRANCH BLOCK AND PERMANENT PACEMAKER IMPLANTATION AFTER EVOLUT R TAVR (2019) (0)
TCT-630 The Impact of Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent for Unprotected Left Main Stenosis (2019) (0)
Efficacy and Safety of an Upfront RotaTripsy Strategy in the Treatment of De Novo and In-Stent Restenosis Cases. (2023) (0)
Iconographies supplémentaires de l'article : Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction With Versus Without Previous Coronary Artery Bypass Grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] (2013) (0)
Platinum‐Chromium Everolimus‐Eluting Stents (2016) (0)
Drug eluting stents in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial (2006) (0)
In saphenous vein grafts bigger is not significantly better: an intravascular ultrasound study (2002) (0)
TCT-658 Neurologic Outcomes with Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (0)
PROGNOSTIC VALUE OF ELEVATED C-REACTIVE PROTEIN AMONG DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2021) (0)
Coronary access after valve‐in‐valve transcatheter aortic valve replacement: Time for a prospective study? (2021) (0)
TCT-745 Insights Into Sex Differences in Transfemoral Transcatheter Aortic Valve Implantation From 2007–2018: From the CENTER Collaboration, A Global Patient-Level Analysis of 12,381 Patients (2019) (0)
IMPACT OF CHRONIC KIDNEY DISEASE ON OUTCOMES IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
Abstract 16507: Complex Percutaneous Coronary Intervention Features Worsen Prognosis in Diabetic Patients: Insights From a Large Single-center Registry (2020) (0)
TCT-105 Determinants of Seattle Angina Questionnaire in Multivessel Disease Patients Undergoing Percutaneous Coronary Intervention: Insights From a Single-Center Study (2022) (0)
TEMPORAL TRENDS IN TRANSRADIAL ACCESS DURING PCI IN RELATION TO BLEEDING RISK: INSIGHTS FROM A LARGE SINGLE-CENTER REGISTRY (2020) (0)
To excel or to confirm? That is the question (2011) (0)
PREDICTORS OF NET ADVERSE CLINICAL EVENTS POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (0)
Editorial commentary: in-stent restenosis and cutting balloon. (2002) (0)
761 PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY (2022) (0)
ARE “NEW GENERATION” DES SUPERIOR TO “OLD GENERATION” DES IN REDUCING ADVERSE CLINICAL OUTCOMES AT LONG–TERM FOLLOW–UP: INSIGHTS FROM REAL (REGISTRO REGIONALE ANGIOPLASTICHE DELL'EMILIA–ROMAGNA) MULTICENTER REGISTRY (2013) (0)
Positive geometric remodelling of native denovo coronary lesions predicts clinical restenosis after stent implantation (1999) (0)
Drug-Eluting Stents: A Potential Preemptive Treatment Choice for Vulnerable Coronary Plaques (2011) (0)
Can Recovery of Ventricular Function After Elective Early Postinfarction Revascularization of Asymptomatic Patients Be Predicted by Perfusion/Metabolism SPECT Radionuclide Imaging or Dobutamine Echocardiography? (1998) (0)
TCT CONNECT-305 Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis (2020) (0)
Abstract 4487: Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention: One Year Outcome (2008) (0)
DOES VALVE CHOICE MATTER? A THEORETICAL MODEL COMPARING PROSTHESIS-PATIENT MISMATCH BETWEEN SAPIEN 3 AND EVOLUT R IN TRANSCATHETER AORTIC VALVE REPLACEMENT (2019) (0)
Abstract 18793: Impact of Chronic Kidney Disease on Outcomes in Patients Undergoing Balloon Aortic Valvuloplasty: Results from the BRAVO Study (2012) (0)
Molecular mediators of atherosclerosis (2004) (0)
TCT-539 Novel Predictors of New Persistent Left Bundle Branch Block after Edwards Sapien 3 TAVR. (2019) (0)
PREDICTION OF ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING CORONARY INTERVENTION USING CALCULATION OF SERUM OSMOLALITY (2017) (0)
Impact of lesion length on vascular brachytherapy failure: a comparison of beta (b) versus gamma (g) irradiation in 990 patients (2002) (0)
Abstract 15502: Clinical Outcomes in Patients Undergoing Non-cardiac Surgery Within 1 Year of Pci (2020) (0)
TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
CLINICALLY-BASED PATIENT RISK SCORES AND THE ‘TARGET LESION REVASCULARIZATION PARADOX’ IN PATIENTS WITH MULTI-VESSEL CAD UNDERGOING PCI (2012) (0)
SEX-SPECIFIC PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
Abstract 20415: Incidence of Post-Procedural Myocardial Infarction and Risk of Recurrent Cardiac Events After Coronary Stenting (2016) (0)
PROGNOSTIC UTILITY OF THE SYNTAX SCORE IN PATIENTS WITH SINGLE VS. MULTIVESSEL DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE ACUITY TRIAL (2011) (0)
TCT-78 Transcatheter Aortic Valve Replacement in Patients With Large and Extra-Large Aortic Annuli: Hemodynamic Performance of New-Generation Balloon- and Self-Expandable Aortic Valves. (2019) (0)
INCIDENCE AND RISK FACTORS FOR CONTRAST-INDUCED NEPHROPATHY IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION TRIAL (HORIZONS-AMI) (2011) (0)
Impact of multiple polymorphisms on clinical outcomes after percutaneous coronary intervention (2013) (0)
Abstract 15958: Internal Elastic Lamellar Disruption is Associated With Smooth Muscle and Myofibroblast Cell Hyperplasia in Restenotic Peripheral Vascular Disease (2011) (0)
Abstract 16422: Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes (2011) (0)
Is cardiac surgery backup required for left main stenting? (2022) (0)
TCT-833 Inflammatory Risk Status Is Age-Dependent in Women but Not in Men Undergoing Percutaneous Coronary Intervention (2019) (0)
TCT-202 Safety and Efficacy of Low-Dose Direct Oral Anticoagulants for Atherosclerotic Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials (2021) (0)
TCT-578 Predictive Factors of Early, Late and Very Late Atherothrombotic Events in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
Acute and long-term outcomes of multivessel stenting in patients aged 80 years (2003) (0)
Contrast-Induced Nephropathy Redefined; Impact of Any Acute Kidney Injury on Clinical Outcomes in Patients with ACS undergoing Angiography: Results from the ACUITY Trial (2008) (0)
Efficacy of Long Radiation Treatment in Native In-Stent Restenosis: A Subanalysis From the RENO Registry (2002) (0)
1101-41 Intravascular ultrasound assessment of lesions with sirolimus-eluting stent failure (2004) (0)
TCT-320 Impact of Pre-Procedural High-Sensitivity C-Reactive Protein, LDL-C and SYNTAX Score on Outcomes Following Percutaneous Coronary Intervention (2018) (0)
PROSTHESIS-PATIENT MISMATCH BETWEEN TRANSCATHETER HEART VALVES IN TRANSCATHETER AORTIC VALVE REPLACEMENT (2020) (0)
DRUG-ELUTING VERSUS BARE-METAL STENTS IN TREATMENT OF DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROMES: ANALYSIS FROM THE RANDOMIZED ACUITY TRIAL (2010) (0)
A mobile application for STEMI care optimization: pilot implementation project report (2022) (0)
ANGIOGRAPHIC PHENOTYPE AND CLINICAL OUTCOMES OF PATIENTS WITH MALIGNANCY UNDERGOING PCI (2017) (0)
FEASIBILITY AND VALIDITY OF MEASURING PATIENT-REPORTED HEALTH STATUS AT TIME OF PCI: RESULTS FROM A SINGLE-CENTER QUALITY IMPROVEMENT INITIATIVE (2018) (0)
TCT-542 Impact of Baseline Anemia and Thrombocytopenia on 1-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
P1652Effect of systemic inflammation and coronary artery disease complexity on outcomes after percutaneous coronary intervention (2018) (0)
Effect of randomized prophylactic nitroglycerin on radial artery spasm during transradial catheterization: An analysis based on operator experience (2023) (0)
C-57 | Prevalence and Outcomes of Early Menopause in Women undergoing Transcatheter Aortic Valve Replacement: Insights from the WIN-TAVI Registry (2022) (0)
ecommendations for Successful Training n Methods of Delivery of Biologics for ardiac Regeneration (0)
Site specific systemic delivery of rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model (2003) (0)
TCT-86 Quantification and Impact of the Proportion of Coronary Disease Burden Treated by Percutaneous Coronary Intervention: The SYNTAX Revascularization Index (2014) (0)
Specialized Balloons in Percutaneous Coronary Intervention (2016) (0)
TCT-528 Novel Predictors of New Permanent Pacemaker Implantation After Evolut TAVR (2019) (0)
Braunwald classification of unstable angina correlates with coronary lesion morphology (1996) (0)
FIVE-YEAR FOLLOW-UP OF POLYTETRAFLUOROETHYLENE-COVERED STENTS COMPARED WITH BARE METAL STENTS IN AORTOCORONARY SAPHENOUS VEIN GRAFTS: THE RANDOMIZED BARRICADE TRIAL (2011) (0)
P1664Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration (2018) (0)
RISK AND IMPACT OF DIABETES MELLITUS ON ISCHEMIC EVENTS IN FEMALES AND MALES AFTER PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
Can manual thrombus aspiration improve myocardial reperfusion? (2006) (0)
TCT-6 Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 inhibitors in Contemporary PCI: Results from a Large Single-Center Registry. (2016) (0)
IMPACT OF BODY SURFACE AREA ON OUTCOMES IN WOMEN AND MEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
Historical Perspective of Sirolimus and Paclitaxel‐Eluting Stent Clinical Studies (2016) (0)
RISK-TREATMENT PARADOX IN PREVALENCE AND DETERMINANTS OF POTENT P2Y12 INHIBITOR USE IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2016) (0)
TCT-112 Impact of Race/Ethnicity On 30 Day Readmission After Percutaneous Coronary Intervention: Results From a Multiethnic, Single Center Registry (2014) (0)
TCT-268 Impact of diabetes on outcomes after percutaneous coronary intervention in patients according to race/ethnicity. (2016) (0)
Proceedings from the Society for Cardiovascular Angiography and Interventions 2022 Think Tank: Coronary Session on Calcium Management (2022) (0)
Prevention and Management of Stroke After Transcatheter Aortic Valve Replacement: The Mount Sinai Stroke Initiative. (2023) (0)
Invasive or Conservative Strategy for Stable Coronary Disease. (2020) (0)
1043-48 Impact of cerebrovascular and peripheral arterial disease on outcomes after percutaneous coronary interventions (2004) (0)
TCT CONNECT-379 Adverse Outcomes in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (2020) (0)
TCT-158 Pooled Analysis of Patients Undergoing Complex PCI With the Dual-Therapy COMBO Stent: The MEGA-COMBO Complex-PCI Analysis (2022) (0)
TCT-477 Major Adverse Cardiovascular Events And Bleeding Risk Analysis In Elderly Afibrillation Patients Undergoing Percutaneous Coronary Intervention: The AVIATOR Registry (2014) (0)
Relative Impact of MACE and Varying Definitions of Major Bleeding on Mortality: Results from the HORIZONS-AMI Trial (2008) (0)
UNDERUTILIZATION OF HIGH INTENSITY STATINS IN A CONTEMPORARY HIGH RISK PCI POPULATION (2017) (0)
Frequency and causes of early hospital readmission for chest pain after contemporary coronary stent implantation (2002) (0)
Transfemoral TAVR in Nonagenarians (0)
Abstract 5606: Outcomes of Patients With Acute Coronary Syndromes and Chronic Renal Insufficiency: Prognostic Importance of Troponin Elevation and Role of Adjunctive Antithrombotic Therapy (Analysis From the Acuity Trial) (2009) (0)
Peripheral studies deserve center stage! (2022) (0)
EFFECT OF BIVALIRUDIN VERSUS HEPARIN IN A CONTEMPORARY TAVR POPULATION OF WOMEN: RESULTS FROM THE BRAVO 3 RANDOMIZED TRIAL (2016) (0)
ST Elevation in a Professional Athlete: From the Coronary Care Unit to the Field (2019) (0)
Coronary Dissection and Right Heart Failure Salvaged by PCI With Percutaneous Intraluminal Microaxial RV-Assist Support (2021) (0)
TCT-635 Combined and Independent Impact of Diabetes Mellitus and Elevated C-Reactive Protein Levels on Risk for Death and MI Following PCI: Insights From a Large Single-Center Registry (2019) (0)
TCT-443 Outcomes in Patients With Peripheral Vascular Disease Undergoing Transcatheter Aortic Valve Implantation (2022) (0)
Predictors and prognostic values of CK-MB cardiac enzyme elevation after coronary intervention with radiation treatment in in-stent restenosis (2002) (0)
TCT-228 Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study (2021) (0)
Chronic Total Occlusion Recanalization A Call for a Randomized Trial Reply (2012) (0)
Interventional Cardiology Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2011) (0)
Coronary stent infections - A systematic review and meta-analysis. (2023) (0)
Exercise Physiology in the Cath Lab: Still Alive and Well! (2012) (0)
Gamma vascular brachytherapy neutralizes the negative impact of diabetes mellitus on clinical outcomes after PCI for in-stent restenosis: pooled data from Gamma I, Gamma II, and SCRIPPS III trials (2002) (0)
Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock (2017) (0)
Trends in Vascular Access Site Use and Outcomes in Patients Undergoing PCI. (2023) (0)
Given the Same Dose of Heparin as Nondiabetics During Percutaneous Coronary Intervention (2003) (0)
Tailoring the therapy to the patient with mitral and tricuspid regurgitation to avoid adverse long‐term outcomes (2022) (0)
NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY (2015) (0)
Abstract 16973: Prevalence, Determinants, and Impact of Target Lesion Calcification in Patients Undergoing Percutaneous Coronary Intervention With Newer Generation Drug Eluting Stents: Findings From a Large Multiethnic Registry (2015) (0)
TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry (2020) (0)
Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial. (2023) (0)
DIFFERENTIAL IMPACT OF FEMALE GENDER ON MORTALITY BY PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE FOLLOWING PCI: RESULTS FROM A SINGLE–CENTER REGISTRY WITH 15,990 PATIENTS (2013) (0)
P2331Association between serum osmolality and acute kidney injury after percutaneous coronary intervention: a simple tool for acute kidney injury prediction (2017) (0)
Long-term favorable coronary healing after bioresorbable scaffold implantation: insights from OCT. (2014) (0)
P4554Impact of the presence of chronic kidney disease on 1-year target lesion failure in patients treated with a dual-therapy stent (2018) (0)
DRUG ELUTING STENTS VERSUS BARE METAL STENTS IN SAPHENOUS VEIN GRAFT INTERVENTION: AN UPDATED META-ANALYSIS OF RANDOMIZED TRIALS (2018) (0)
Transcatheter valve‐in‐valve for failing bioprosthetic aortic valve: Usually a good idea (2018) (0)
Reduced gastric injury with a novel, liquid lipid-aspirin formulation: results from a pooled, patient level analysis of two randomized endoscopy studies In healthy volunteers (2020) (0)
Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost (2021) (0)
THE ALIGNMENT OF TRANSCATHETER AORTIC VALVE NEO-COMMISSURES (ALIGN TAVR) STUDY (2020) (0)
Erratum: Bifurcation coronary lesions treated with the "crush" technique: An intravascular ultrasound analysis (Journal of American College of Cardiology (2005) 46 (599-605)) (2005) (0)
TCT-445 Patients with 3-vessel Coronary Artery Disease and Impaired LVEF undergoing PCI with Impella 2.5 Hemodynamic Support Have Improved 90-Day Outcomes Compared to Intra-Aortic Balloon Pump: A Substudy of The PROTECT II Trial (2013) (0)
TCT-163 Do Patients with Paroxysmal Atrial Fibrillation in Sinus Rhythm during PCI Require Triple Therapy? Results from a Multicenter Center Study (2013) (0)
INCOMPLETE THREE-VESSEL INTRAVASCULAR IMAGING IN THE PROSPECT TRIAL: IMPLICATIONS FOR PRE-EMPTIVE VULNERABLE PLAQUE DETECTION (2010) (0)
TCT-662 Patients Who Do Not Receive Drug-Eluting Stent for In-Stent Restenosis: Characteristics and Outcomes (2019) (0)
TCT-798 Evaluation of sex-differences in one-year clinical outcomes among patients treated with the dual-therapy COMBO stent: From the COMBO Collaboration (2018) (0)
Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women. (2022) (0)
TCT CONNECT-162 Predictors of Adverse Events in Patients Undergoing Cardiac Surgery Within 1 Year of PCI (2020) (0)
Imaging in Percutaneous Coronary Intervention (2022) (0)
Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation. (2023) (0)
P1663COMBO stent PCI for elderly patients: one year clinical outcomes and DAPT cessation patterns from the global MASCOT registry (2018) (0)
Overlapping bio‐absorbable scaffolds: Aim for D2D technique? (2018) (0)
Combination antiplatelet/antithrombotic regimens after stenting: Are we forcing too much in this decision? (2021) (0)
Technical Tips and Imaging in Aortoiliac Intervention Considerations in selecting noninvasive imaging modalities for use in treating peripheral arterial disease (0)
Ticagrelor with or without Aspirin after PCI. Reply. (2020) (0)
Abstract 16599: Impact of Race and Ethnicity on Long Term Outcomes Post Percutaneous Coronary Intervention With Drug Eluting Stents (2020) (0)
Anticoagulation and Subclinical Valve Thrombosis After TAVR. (2022) (0)
Abstract 19783: A Prediction Model for Long Term Mortality after PCI: Results from the NCDR (2010) (0)
Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight. (2023) (0)
CHANGES IN LV EJECTION FRACTION AND OUTCOMES AFTER PCI IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY (2023) (0)
Transcatheter Cardiovascular Therapeutics 2018. (2019) (0)
COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI (2011) (0)
Prognostic role of troponin T and troponin I in patients with acute coronary syndromes: Meta-analysis of 20 studies (2003) (0)
IMPACT OF ANEMIA IN MEN AND WOMEN WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE HORIZONS-AMI TRIAL (2010) (0)
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention with Drug Eluting Stents. (2020) (0)
Oral Antiplatelet Agents in PCI (2016) (0)
Impact of Blood Transfusion and Other Bleeding Measures on Subsequent Mortality Among Patients Undergoing Primary PCI for Acute Myocardial Infarction: The HORIZONS-AMI Trial (2008) (0)
Abstract 19521: Impact of Procedural Complications on Survival in Patients with Severe Aortic Stenosis Treated with Balloon Aortic Valvuloplasty: Results from the BRAVO Study (2012) (0)
Rationale and Technique for Percutaneous Coronary Intervention of Chronic Total Occlusions (2015) (0)
Abstract 20664: Is Aspirin Needed as an Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Coronary Intervention? (2017) (0)
TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
BLEEDING RISK IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2021) (0)
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y 12 receptor antagonist, in patients with chronic coronary syndromes Thrombosis and antithrombotic therapy (2020) (0)
Abstract 10275: Open versus Endovascular Stent Graft Repair of Abdominal Aortic Aneurysms: Meta-Analysis of Prospective Randomized Controlled Trials (2011) (0)
Abstract 18591: Anatomically- Versus Clinically-derived Risk Scores Have Markedly Differing Predictive Abilities Following PCI For Multivessel CAD: The "TLR Paradox" (2012) (0)
Left Main PCI With DES Versus CABG (2018) (0)
TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis (2021) (0)
Interventional Cardiology Education Through Structured Case Reviews (2019) (0)
CORRELATION OF THROMBUS AREA WITH ANGIOGRAPHIC AND CLINICAL OUTCOMES IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI: ANALYSIS FROM THE HORISONS-AMI TRIAL (2010) (0)
TCT-417 Influence of Thrombotic and Bleeding Risk on P2Y12 Receptor Inhibitor Choice in ACS After PCI: Insights From a Large Single-Center Registry (2019) (0)
Is bigger better with vascular brachytherapy (VBT) for in-stent restenosis? Impact of optimal final angiographic results and predictors of restenosis in 990 VBT patients (2002) (0)
Abstract 3438: Impact of Different Pre-dilatation Strategies on Stent Expansion: An Intravascular Ultrasound Study (2006) (0)
SYNERGISTIC EFFECTS OF CORONARY CALCIFICATION AND INFLAMMATION ON RISKS FOR ADVERSE CARDIOVASCULAR EVENTS AFTER PCI: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2017) (0)
31 INTRACORONARY ULTRASOUND (1999) (0)
In‐Stent Restenosis in the DES Era (2011) (0)
Coronary In-Stent Restenosis: An Algorithmic Approach to Diagnosis and Treatment (2019) (0)
TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. (2016) (0)
Redefining landmarks to improve #safefemoral outcomes (2019) (0)
TCT-217 Efficacy of Dual Antiplatelet Therapy in Women with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (0)
Myocardial infarction after cardiac surgery: When to intervene? (2021) (0)
IMPACT OF POTENT P2Y12 INHIBITOR USE VERSUS CLOPIDOGREL IN REAL-WORLD PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2016) (0)
ole of the Endothelium in odulating Neointimal Formation asculoprotective Approaches to Attenuate estenosis After Percutaneous Coronary Interventions (2004) (0)
Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part I: Bifurcations, Left Main Disease, and Calcifications (2022) (0)
CLINICAL OUTCOMES BY SEX AND ETHNICITY AFTER PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
Outcomes of bivalirudin in moderate and high risk patients with acute coronary syndromes and renal insufficiency: An ACUITY substudy (2007) (0)
Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single‐center registry (2020) (0)
DOES ORIENTING SAPIEN3 DURING CRIMPING IN TAVR AFFECT FINAL ORIENTATION TO CORONARIES TO IMPACT CORONARY REACCESS? A PILOT STUDY (2019) (0)
Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent. (2020) (0)
PREVALENCE AND PROGNOSTIC IMPACT OF HIGH BLEEDING RISK STATUS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE (2021) (0)
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry. (2022) (0)
Abstract 1145: Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis from 14 Randomized Clinical Trials (2008) (0)
Abstract 3347: Sirolimus Eluting Stents In Single Vessel Versus Multi-vessel Percutaneous Coronary Intervention: Results From The Matrix Registry (2007) (0)
CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy (2021) (0)
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: insights from a large PCI registry. (2023) (0)
TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
TCT-543 Clinical and Procedural Risk Predictors of Acute Kidney Injury Following Transcatheter Aortic Valve Replacement: Findings From a Real-World Registry (2022) (0)
Intersection of the Academic Research Consortium – high bleeding risk criteria in patients undergoing PCI for acute coronary syndromes: insights from a high-volume single centre registry (2020) (0)
Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention (2022) (0)
Invasive management of the acute coronary syndromes (2012) (0)
TCT-466 Bivalirudin Is Associated With Improved In-Hospital Outcomes After Peripheral Arterial Interventions: An Observational Analysis On 23,934 Patients From The PREMIER Hospital Database (2014) (0)
Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes. (2023) (0)
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION COMPLEXITY IN REAL-WORLD PRACTICE (2019) (0)
The Optimal Duration of Dual Combination Antiplatelet Therapy After Stent Implantation and Perioperative Management Issues. (2013) (0)
TCT-791 Impact of Clinical Judgement on Risk Stratification of Patients at High Risk for TAVR: A BRAVO-3 Subgroup Analysis (2017) (0)
TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
Relative Prognostic Utility of Different Bleeding Scales Among Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction: The HORIZONS-AMI Trial (2008) (0)
Beta versus gamma radiation for treatment of in-stent restenosis: angiographic predictors and outcomes in 630 patients (2002) (0)
Outcomes of Patients with Acute Coronary Syndromes and Non-obstructive Coronary Artery Disease: Analysis from the Randomized ACUITY Trial (2009) (0)
TCT-485 Effect of Gender on Clinical Outcomes in Patients With or Without Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Results from a Large Single Center Registry (2015) (0)
Bolus-only glycoprotein IIb/IIIa inhibitor revisited. (2006) (0)
TCT CONNECT-56 Prolonged Dual Antiplatelet Therapy in Patients With or Without Prior Myocardial Infarction: An Updated Systematic Review and Meta-Analysis (2020) (0)
TCT-285 Stent Diameter and Clinical Outcomes After PCI: From the COMBO MASCOT and REMEDEE Collaboration (2019) (0)
Abstract 11826: Association of Bleeding, Mortality and Gender in Acute Coronary Syndromes: The "Gender Triangle" . A Gender-based Prospective Observational Study From Real Registry (2012) (0)
TCT-39 Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index: TWILIGHT-BMI Analysis (2021) (0)
Does vessel size have an impact on recurence rates following gamma vascular brachytherapy: acute and nine-month results from SCRIPPS III registry (2002) (0)
TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI (2022) (0)
IMPACT OF VASCULAR CLOSURE WITH THE PRE-CLOSURE TECHNIQUE ON ADVERSE EVENTS IN PATIENTS UNDERGOING TRANSFEMORAL BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER registry (2012) (0)
Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis. (2022) (0)
Parenteral Anticoagulant Agents in PCI (2016) (0)
TCT-218 Balancing The Risk Between Myocardial Infarction and Clinically Significant Bleeding With Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation (2015) (0)
TCT-400 Everolimus-Eluting Stent and Dedicated 2-Stent Strategy in Complex 'True' Bifurcation Lesion with Major Side Branch Involvement (2013) (0)
Improved Commissural Alignment in TAVR With the Newest Evolut FX Self-Expanding Supra-Annular Valve: First-in-Human Experience. (2022) (0)
Role of an optical reflectometry and radiofrequency ablation device: coronary chronic total occlusions (2007) (0)
Optimal Stent Expansion: An Intrsvasculsr Ultrasound Study (2013) (0)
Risk prediction in cardiogenic shock (2021) (0)
TCT-496 Differences in quantitative coronary angiographic (QCA) characteristics of coronary artery disease between Human Immunodeficiency Virus (HIV) patients presenting with acute coronary syndrome (ACS) and stable angina pectoris (SAP) undergoing percutaneous coronary intervention (PCI). (2016) (0)
PLAQUE MORPHOLOGY PREDICTORS OF SIDE BRANCH OCCLUSION AFTER MAIN VESSEL STENTING IN CORONARY BIFURCATION LESION: OPTICAL COHERENCE TOMOGRAPHY IMAGING STUDY (2016) (0)
IMPACT OF BODY MASS INDEX ON MAJOR BLEEDING AFTER PCI: ONE-YEAR RESULTS FROM THE MULTICENTER PROSPECTIVE PARIS REGISTRY (2013) (0)
DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI (2011) (0)
Pharmacological use of ethanol for myocardial septal ablation (2007) (0)
STROKE AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: INCIDENCE AND TEMPORAL TRENDS BETWEEN 2007 AND 2022 (2023) (0)
Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis (2021) (0)
TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY (2021) (0)
B-TYPE NATRIURETIC PEPTIDE AND THE RISK OF CONTRAST INDUCED NEPHROPATHY IN STEMI: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2012) (0)
Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better (2021) (0)
Vascular brachytherapy for ostial in-stent restenotic lesions (2002) (0)
TCT-452 Predictors of Prolonged Hospitalization After Transcatheter Aortic Valve Implantation (2022) (0)
Do multiple prior interventions for in-stent restenosis impact the success of gamma brachytherapy? (2002) (0)
Predictors of contrast induced nephropathy after percutaneous coronary intervention in patients with and without chronic renal failure (2002) (0)
TCT-451 Incidence, Correlates and impact of left ventricular ejection fraction improvement on short- and long-term clinical outcome of patients undergoing high-risk percutaneous coronary intervention. A single center experience (2018) (0)
TCT-56 Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results from a Large Single-Center Registry. (2016) (0)
PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI (2021) (0)
Percutaneous coronary interventions in octogenarians with use of glycoprotein GP llb/llla inhibitors: Similar major adverse cardiac events but higher hemorrhagic stroke rate than younger patients (2003) (0)
Myocardial injury myocardial injury markers and anticardiac auto-antibodies. A prospective evaluation of humoral autoimmunity in coronary heart disease* (1999) (0)
TCT-886 Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty (2012) (0)
Volume 112, July 5–December 20/27, 2005 (2005) (0)
A NOVEL MOBILE APPLICATION TO DIAGNOSE AND TRANSFER PATIENTS WITH STEMI IN A LARGE HEALTHCARE SYSTEM: STEMICATHAID (2021) (0)
TCT-278 Clinical Outcomes of All-Comer Patients Presenting With Acute Coronary Syndrome Treated With the COMBO Stent: From the MASCOT and REMEDEE Registry (2019) (0)
Stent Technology Reaches Maturity? (2020) (0)
TCT-390 Clinical and Echocardiographic Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Nominally Sized Annuli (2021) (0)
Impact of vascular closure with the pre-closure technique on adverse events in patients undergoing transfemoral balloon aortic valvuloplasty: results from a single-center registry (2013) (0)
Abstract 16570: Systemic Inflammation Alters the Bleeding-Ischemic Balance in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Interventions (2020) (0)
Are the minor high bleeding risk criteria of the academic research consortium truly minor? Insights from a high-volume tertiary care pci centre (2020) (0)
Tackling chronic total occlusions: training standards and recommendations (2007) (0)
Abstract 16974: Gender Differences in Patients Undergoing Transcatheter Aortic Valve Replacement: a Single Center Experience (2014) (0)
Management of Patients after Acute Coronary Syndrome (2014) (0)
Intravascular ultrasound guidance decreases target lesion revascularization in long-diffuse coronary lesions (2002) (0)
Impact of dual antiplatelet non-adherence after percutaneous coronary intervention in patients with or without history of myocardial infarction (2021) (0)
WHAT IS THE UNDERLYING PLAQUE MORPHOLOGY OF CORONARY THROMBOSIS? AN ANGIOSCOPIC AND VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND CORRELATIVE STUDY (2010) (0)
TCT-438 Impact of concomitant coronary artery disease on risk for short-term MACCE in patients after TAVR (2017) (0)
TCT-463 Does Routine Post-Procedural Anticoagulation Reduce Acute Stent Thrombosis after Bivalirudin Anticoagulation During Primary PCI? The HORIZONS-AMI Trial (2014) (0)
TCT-159 Balloon-Expandable or Self-Expandable Valves in Valve-in-Valve Transcatheter Aortic Valve Implantation? (2021) (0)
Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock. (2022) (0)
Abstract 20362: Gender Differences in Percutaneous Coronary Intervention for Chronic Total Occlusions: a Report from the 1,781 Patient Multinational CTO Registry (2010) (0)
Effects of Body Mass Index on ClinicalOutcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (2017) (0)
Abstract 16790: Myocardial Injury is an Independent Predictor of Mortality in Patients With COVID-19 (2020) (0)
CRT-100.06 Differences in Quantitative Coronary Angiographic (QCA) Characteristics of Coronary Artery Disease and Clinical Outcomes Between Statin Pre-treated and Statin-Naïve Human Immunodeficiency Virus (HIV) Patients Undergoing Percutaneous Coronary Intervention (PCI) (2017) (0)
Impact of body mass index on outcomes in patients undergoing percutaneous coronary intervention for in-stent restenosis (2022) (0)
Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis (2022) (0)
DUAL ANTIPLATELET THERAPY AND LONG-TERM CLINICAL OUTCOMES AFTER PRIMARY PCI: THE HORIZONS-AMI TRIAL (2012) (0)
Abstract 19212: Clinical Outcomes More Than 12 Months After PCI in Diabetic Patients With or Without DAPT: Results From the FREEDOM Trial (2016) (0)
Acute Coronary Compendium Reperfusion Strategies in Acute Coronary Syndromes (2014) (0)
Radial versus femoral access for coronary angiography and interventions: a systematic review and meta-analysis of randomized trials (2020) (0)
TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry. (2016) (0)
IMPELLA OR INTRA-AORTIC BALLOON PUMP SUPPORT IN PATIENTS UNDERGOING HIGH RISK PERCUTANEOUS CORONARY INTERVENTION: A REAL WORLD SINGLE CENTER EXPERIENCE (2017) (0)
Sodium bicarbonate, contrast-associated acute kidney injury, and long-term outcomes: The end of an era? (2021) (0)
ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
Abstract 21306: Impact of Insulin Treated Diabetes Mellitus on 1 Year Outcomes After Contemporary PCI (2017) (0)
INCIDENCE, PREDICTORS AND IMPACT OF POST-PROCEDURAL BLEEDING FOLLOWING IMPELLA-ASSISTED HIGH-RISK PCI (2022) (0)
Abstract 13775: Dual vs. Triple Antithrombotic Therapy After Coronary Stenting in Patients With Non-Valvular Atrial Fibrillation (2013) (0)
Abstract 11314: Inverse Relationship Between Body Mass Index and Coronary Artery Calcification in Older Patients with Clinically Significant Coronary Lesions (2011) (0)
Emergency management of ST-elevation myocardial infarction (2013) (0)
CORONARY ARTERY DISEASE BURDEN AND CLINICAL OUTCOMES IN PATIENTS WITH HUMAN IMMUNE DEFICIENCY VIRUS (HIV) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A SINGLE-CENTER REGISTRY (2014) (0)
TCT-296 Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation Is Associated With Increased Mortality (2021) (0)
Percutaneous Coronary intervention in Small Coronary Arteries (2002) (0)
DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
TCT-414 Dedicated 2-stent versus 1-Stent Strategy in Diabetic Patients with Complex 'True' Bifurcation Lesion PCI using Everolimus-Eluting Stent (2013) (0)
IVUS PREDICTORS OF EARLY STENT THROMBOSIS AFTER PRIMARY PERCUTANEOUS INTERVENTION IN ACUTE MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2010) (0)
TCT-444 Diabetes Mellitus in Transfemoral Transcatheter Aortic Valve Implantation: A Propensity Matched Analysis (2022) (0)
Abstract 15867: Contemporary Percutaneous Treatment of In-Stent Restenosis in the United States: Insights From a Large Single-Center Registry (2018) (0)
Catheter-Based Local Delivery of Therapeutics to the Lungs for Severe or Critically Ill Patients with COVID-19 (2021) (0)
IMPACT OF ACUTE KIDNEY INJURY ON OUTCOMES IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY (2013) (0)
Antithrombotic Strategies after Transcatheter Valve Implant Transcatheter Aortic Valve Replacement (2018) (0)
Dangas bivalirudin heparin TAVR BRAVO 3 appendix JACC 12 2015 (2015) (0)
TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
Geographic miss is not associated with restenosis or the edge phenomenon in the INHIBIT trial (2002) (0)
Clinical investigation in ACS and PCI: Shooting in the dark at a moving target (2009) (0)
PREDICTORS OF HIGH INTENSITY STATIN USE AFTER PERCUTANEOUS CORONARY INTERVENTIONS (2017) (0)
Low stroke rates during carotid artery stenting with neuroprotection (2003) (0)
P2069Multivessel PCI versus culprit-vessel only PCI in patients with acute myocardial infarction and multivessel disease (2017) (0)
MYOCARDIAL ISCHEMIA AND INFARCTION RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2011) (0)
Comparison of “conventional” wall motion and perfusion imaging with F18-FDG spect imaging for myocardial viability (1997) (0)
Determinants of Seattle Angina Questionnaire in multivessel disease patients undergoing percutaneous coronary intervention: Insights from a single-center study. (2023) (0)
Impact of smoking habit on clinical outcomes after percutaneous coronary intervention (2002) (0)
Rotational Atherectomy of an Underexpanded Stent (2004) (0)
Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital Versus Out-of-Hospital (2012) (0)
TCT CONNECT-378 Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single-Center Large-Volume PCI Registry (2020) (0)
Duration of Dual Antiplatelet Therapy AfterDrug-Eluting Stent Implantation (0)
TCT-404 Benefit and Risks of Aspirin on Top of Ticagrelor in Acute Coronary Syndromes: Insights From the Randomized GLOBAL LEADERS Trial (2019) (0)
Heparin, LMWH, GIIb/IIIa, and Direct Thrombin Inhibitors (2011) (0)
IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL (2011) (0)
Defining Key Features of Complex Coronary Lesions: An Evidence Based Review of Clinical Practice. Part II: Chronic Total Occlusions, Graft Interventions, In-Stent Restenosis, and Antithrombotic Strategies (2022) (0)
Transcatheter valves are a viable option for degenerative surgical mitral bioprostheses (2019) (0)
Long-term outcomes in high-bleeding risk patients undergoing PCI for acute coronary syndromes: results from a large single-center pci registry (2020) (0)
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement (2023) (0)
NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY (2015) (0)
TCT-480 Outcomes in Patients with Non-obstructive Coronary Artery Disease With and Without Cardiac Biomarker Elevations: The ACUITY Trial (2012) (0)
Hemostasis for Cardiac Catheterization (2015) (0)
Comprar Interventional Cardiology | Peter Barlis | 9781405178877 | Wiley (2010) (0)
Dual versus single antiplatelet therapy after TAVR: Let's not mix apples and oranges. (2021) (0)
Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis (2022) (0)
TCT-39 Mobile Application Improves Quality of Care for Patients With STEMI (2022) (0)
IS OBSTRUCTIVE SLEEP APNEA ASSOCIATED WITH SUB-CLINICAL CAROTID ATHEROSCLEROSIS IN THE ABSENCE OF TRADITIONAL RISK FACTORS? A META-ANALYSIS OF 2053 PATIENTS (2019) (0)
Abstract 6089: Myocardial Blush Predicts Outcomes in Patients with Acute Coronary Syndromes: An Analysis of the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial (2008) (0)
EFFECT OF SYSTEMIC INFLAMMATION ON OUTCOMES AFTER COMPLEX PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
Abstract 4509: Individual Patient Risks of Major Bleeding and Myocardial Infarction and Their Implications for Mortality and for Treatment Choice in Acute Coronary Syndromes: Findings From the ACUITY Trial (2009) (0)
1101-45 Contribution of stent underexpansion to target lesion revascularization after sirolimus-eluting stenting for in-stent restenosis (2004) (0)
TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL (2022) (0)
COMPARISON OF THE PROGNOSTIC UTILITY OF VARIOUS CLINICAL AND ANGIOGRAPHIC RISK SCORES IN PATIENTS WITH ACUTE CORONARY SYNDROMES: ANALYSIS FROM THE ACUITY TRIAL (2011) (0)
TCT CONNECT-47 Impact of Sex at Birth on Long-Term Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome (2020) (0)
TCT-330 Risk phenotype and clinical outcomes of patients with stable coronary artery disease treated with PCI stratified by baseline LDL cholesterol. (2016) (0)
PHYSICIAN CHOICE OF DISCHARGE ANTITHROMBOTIC REGIMEN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION BASED ON BLEEDING AND ISCHEMIC RISK ASSESSMENT: RESULTS FROM AVIATOR MULTI-CENTER REGISTRY (2014) (0)
octogenarians: navigate with caution Primary percutaneous coronary intervention in (2010) (0)
Left Main PCI With DES Versus CABG: Cautionary Note or Cause for Concern? (2018) (0)
TCT-225 Impact of Age on the Disruption of Dual Antiplatelet Therapy: Analysis from the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented) Patients Registry (2015) (0)
Same‐day discharge after left atrial appendage occlusion: Is ICE‐guided LAAO ready for prime time? (2022) (0)
TCT-217 Predictors of Dyspnea in Patients Receiving Ticagrelor After PCI: Insights From the Twilight Trial (2021) (0)
Chronic total occlusions (2021) (0)
CLINICAL OUTCOMES ASSOCIATED WITH IMPELLA VERSUS IABP USE IN STABLE PATIENTS UNDERGOING HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
Abstract 18932: Safety and Efficacy of New- vs. Early-Generation Drug-Eluting Stents in Elderly Women: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (0)
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial. (2022) (0)
TCT-529 Novel Predictors New Persistent Left Bundle Branch Block After Evolut TAVR (2019) (0)
TCT-490 Frequency And Impact Of Nuisance Bleeding On Adverse Events After Percutaneous Coronary Intervention: 2-Year Results From The Patterns Of Non-Adherence To Antiplatelet Regimens In Stented Patients (PARIS) Registry (2014) (0)
IMPACT OF LEFT VENTRICULAR DYSFUNCTION ON OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AVIATOR REGISTRY (2015) (0)
PERFORMANCE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA ACCORDING TO SEX (2020) (0)
Minimally invasive coronary bypass surgery in octogenarians: Perioperative outcome and comparison with younger age groups (2000) (0)
TAVR Through Heavily Calcified Aorta Following Atheroma Retrieval With the "Elevator" Technique. (2015) (0)
Combination Antithrombotic Management of STEMI with Pharmacoinvasive Strategy, Primary PCI, or Rescue PCI. (2013) (0)
Antithrombotic Strategies in Valvular and Structural Heart Disease Interventions (2013) (0)
Does genetic polymorphism for platelet glycoprotein illa impact early and long-term outcomes after elective percutaneous coronary interventions? (2003) (0)
Abstract 18678: Transcutaneous Aortic Valve Replacement -Is Anticoagulation Protective? (2014) (0)
TCT-222 Combined and independent impact of diabetes mellitus and chronic kidney disease on clinical outcomes by SYNTAX score in patients undergoing PCI (2017) (0)
TCT 2009: New Findings Pave the Way for Novel Approaches to Treating Cardiovascular Disease (2010) (0)
Abstract 19992: Impact of Successful Percutaneous Coronary Intervention of a Chronic Total Occlusion: Five-Year Outcomes from a 1,781 Patient Multinational Registry (2010) (0)
Endovascular treatment of infrarenal aortic stenosis: importance of multimodality imaging. (2011) (0)
RESIDUAL INFLAMMATORY RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
Abstract 11903: The FREEDOM Trial: A Snapshot at Randomization (2011) (0)
TRANSRADIAL VS. TRANSFEMORAL APPROACH FOR PRIMARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL. (2010) (0)
IMPACT OF SMOKING AND ALTERNATIVE ANTITHROMBOTIC STRATEGIES ON OUTCOMES OF PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) TRIAL (2010) (0)
TCT-335 Impact of Age on Sex-Based Differences on Cardiovascular Risk Between Men and Women Undergoing PCI: Results from a Large Single-Center Registry with Over 18,000 Patients. (2016) (0)
"Nothing Aches Like A Heart". (2019) (0)
In-stent restenosis in the drug-eluting stent era (2018) (0)
Impact of Major Adverse Cardiac Events and Major Bleeding on Overall Mortality in Patients with Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial (2008) (0)
Chapter 7 – Treatment with Drug-Eluting Stents (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With George D Dangas?

George D Dangas is affiliated with the following schools:

Yale University
American College of Cardiology
Showa University
Icahn School of Medicine at Mount Sinai
National and Kapodistrian University of Athens
Columbia University
Paris Diderot University
Duke University

George D Dangas's Academic­Influence.com Rankings

George D Dangas's Degrees

Why Is George D Dangas Influential?

George D Dangas's Published Works

Published Works

What Schools Are Affiliated With George D Dangas?

George D Dangas's AcademicInfluence.com Rankings